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ABSTRACT OF DISSERTATION

Determination of farm-specific Lawsonia intracellularis seroprevalence in central
Kentucky Thoroughbreds and the identification of factors contributing to equine
proliferative enteropathy

Lawsonia intracellularis and the disease it causes in horses, equine proliferative
enteropathy (EPE), is an emerging pathogen of increasing importance to the horse
industry from both an economic and welfare standpoint. Long recognized as an
economically important disease of swine, the hallmark of EPE is a protein-losing
enteropathy, where affected horses suffer weight loss and some ultimately succumb to the
disease despite aggressive treatment. There are currently no known EPE preventative
measures and the epidemiology of the disease remains poorly defined. While EPE is a
sporadic disease affecting less than 25% of exposed horses, some farms experience
clinical cases year after year. Further, weanlings are uniquely susceptible to this disease,
although no conclusive reason for this predisposition has been identified. The overall
hypothesis is that the host immune response plays a significant role in the susceptibility
of weanlings to L. intracellularis infection and the occurrence of clinical equine
proliferative enteropathy. To test this hypothesis, four individual hypotheses were
proposed: (H1) previous farm history of EPE does not have an effect on weanling
seroprevalence, (H2) passively-acquired antibodies do not have an effect on susceptibility
to L. intracellularis and the occurrence of EPE, (H3) the serological status of mares can
be used to determine the role they play in the epidemiology of EPE on endemic farms,
and (H4) L. intracellularis-specific IFN-γ expression is not associated with increased
resistance to EPE.
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CHAPTER ONE:
Introduction & Literature Review

Section I: Lawsonia intracellularis and Equine Proliferative Enteropathy

Lawsonia intracellularis
Lawsonia intracellularis is the causative bacterial organism of proliferative
enteropathies in a variety of species, but most notably in pigs, horses, and hamsters.1
First described in pigs by Biester and Schwarte,2 it wasn't until 1973 that proliferative
enteropathy was attributed to a bacterium.3 Difficulty with isolation, cultivation, and
characterization delayed naming of the bacterium until 1995 when it was formally named
Lawsonia intracellularis.4 L. intracellularis has been classified as a member of the delta
subdivision of the Proteobacteria class, with closest genetic homology (91%) to
Desulfovibrio desulfuricans.4 L. intracellularis is an obligately intracellular, flagellated,1
curved, gram-negative rod which measures approximately 1.25-1.75 µm in length and
0.26-1.5 µm in width,4,5 requiring a reduced oxygen atmosphere for in vitro cultivation.5,6
L. intracellularis is best recognized for causing porcine proliferative enteropathy
(PPE), an economically devastating disease in the porcine industry due to its detrimental
effect on average daily gain and market weight.7,8 As a result, the majority of what is
known with respect to L. intracellularis has been discovered through work with pigs and
largely extrapolated to the horse. Porcine proliferative enteropathy encompasses several
clinical entities, including the subclinical form in which affected pigs exhibit no clinical
signs but shed the bacterium, the chronic form where affected pigs fail to grow as well as
littermates (porcine intestinal adenomatosis), and the acute form (normally referred to as
13

porcine hemorrhagic enteritis or PHE), which is often characterized by hemorrhagic
diarrhea and acute death.1 While acute morbidity and mortality has long been recognized
as a common clinical presentation of Lawsonia intracellularis infection in swine,1 only
recently has work demonstrated a similar presentation in horses, called the necrotizing
form of EPE (N-EPE)(See Appendix), which, like PHE, leads to rapid clinical
deterioration and death.9 Likewise, most EPE-affected horses exhibit signs similar to
those of chronic PPE pigs with a more prolonged and less-severe outcome while a small
portion of horses will experience subclinical EPE.10

Equine Proliferative Enteropathy Introduction
Equine proliferative enteropathy (EPE) is an emerging disease of young horses
with important economic and welfare concerns.9,11 Whether EPE is truly emerging or is
more common as a result of better recognition by veterinarians and horse owners is not
known, although unpublished data suggests that exposure to L. intracellularis in
Kentucky has remained fairly static over that past 7+ years.12 Proliferative enteropathy
was first reported in a horse from California by Duhamel and Wheeldon in 1982, when
the disease was still referred to as “intestinal adenomatosis”,13 while Williams et al.14 in
1996 published the first report of EPE in a horse from Kentucky using the correct name
of L. intracellularis. Since then, an expansive distribution of EPE has now been
published across the world, although no cases have been reported in the literature, to date,
in Asia or Africa.15-18
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EPE Clinical Signs
The clinical signs associated with EPE are relatively non-specific and include
anorexia, fever, dependent edema, depression, lethargy, rapid weight loss, and an
unthrifty appearance/hair coat, while colic and diarrhea have been occasionally
reported.11,18 EPE is typically seen in weanlings, a common characteristic of all L.
intracellularis-induced PE's, with most cases in central Kentucky occurring between
August and February.11,19,20 Most affected horses will respond well to treatment (see
below) although some may develop secondary complications, such as salmonellosis or NEPE, which may prolong the recovery period or result in death. For those horses that do
recover, the recovery period can take weeks to months before they regain the appearance
of unaffected cohorts (author's personal experience).
Unique amongst the species that L. intracellularis infects, hypoproteinemia and
hypoalbuminemia are considered one of the antemortem hallmarks of EPE11 and the
reason that dependent edema is seen with EPE cases. Loss of protein and albumin
through an unknown mechanism, likely a combination of decreased food intake,
malabsorption,21 and possibly protein loss through compromised small intestine,9 results
in lower plasma oncotic pressure and a net movement of free fluid from the circulation
into tissues.

Treatment of EPE
Treatment of EPE requires the use of antimicrobials that reach therapeutic
concentrations within the cytoplasm of infected enterocytes because of the intracellular
location of the pathogen. A variety of various antimicrobials have been demonstrated to
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exhibit in vitro inhibition of L. intracellularis;22,23 primarily the use of chloramphenicol,
macrolides with or without rifampin, and tetracycline-related drugs have been
described.16,18,24-26 If it is needed, supportive care of affected horses is typically aimed at
restoring circulating oncotic pressure through the use of equine plasma or synthetic
colloids.11 Horses with severe anorexia and weight loss may require partial or total
parenteral nutrition in a hospital setting. Further, horses with antemortem signs of NEPE require immediate and aggressive care to blunt the sequelae that result in these
cases; treatment with broad-spectrum antimicrobials to ensure coverage against both
Gram-positive and Gram-negative bacteria, anti-thrombotics, and anti-endotoxic
measures such as low-dose flunixin meglumine27 and/or intravenous polymyxin-B.28
Due to their potential nephrotoxic effects, care should be taken when administering nonsteroidal anti-inflammatory drugs and/or polymyxin-B; likewise, tetracycline-class drugs
(particularly intravenous oxytetracycline) can be nephrotoxic and should be used
carefully in hypovolemic patients.29

Antemortem Diagnostic Tests for EPE
Given that the hallmark of proliferative enteropathies caused by L. intracellularis
is mucosal hyperplasia, abdominal ultrasonography can be a useful diagnostic test in
horses. Small intestinal wall thickness in excess of 3mm anywhere in the abdominal
cavity of young horses is suggestive of EPE,19 while increased thickness is highly
suspicious for EPE when accompanied by compatible clinical and/or clinicopathologic
signs. Care should be exercised when no small intestinal thickening is observed as there
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have been reports of clinical EPE cases where wall thickness was reported to be within
normal limits.11
In horses, it is well reported that hypoalbuminemia and hypoproteinemia are nonspecific, but highly suggestive findings seen with EPE.11,18,30 These changes likely
reflect both protein loss and malabsorption in the affected small intestine. As a result,
and as demonstrated in previous studies, total protein and albumin levels can drop rapidly
in the span of 4-7 days.10 While reference ranges will vary based on the population and
testing method, total protein concentrations below 5.3 mg/dL and albumin concentrations
below 3.2 mg/dL should be considered hypoproteinemic and hypoalbuminemic,
respectively (see Chapter 3 below). It is important to note though that there are a number
of conditions, including renal disease, colitis, salmonellosis, and intestinal parasites, that
can also result in decreased in albumin levels. With respect to other clinicopathologic
testing, complete blood counts, and fibrinogen levels19 are not typically considered useful
for EPE screening because routine clinical cases of EPE are devoid of a detectable
intestinal inflammatory response1 and L. intracellularis infection is primarily localized to
the intestinal enterocytes. Additionally, metabolic derangements are rare unless severe
diarrhea is present, the case has been ongoing for a prolonged period of time, or there is
concurrent disease.11,31
Fecal polymerase chain reaction (PCR) for L. intracellularis is probably the most
specific test available in that it detects sequences of DNA unique to the bacterium.1,32
Issues arise, however, with L. intracellularis PCR in that the bacterium may be
intermittently shed by infected horses and there are a variety of PCR inhibitors in feces.33
Further, fecal shedding of the bacterium in horses has been reported to stop within 4-6
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days of antimicrobial administration.30 It is likely for these reasons that the sensitivity of
L. intracellularis-specific fecal PCR testing is variable.32,34-36
Currently, there are several L. intracellularis-specific serologic assays available
for use in horses. The original assay, the immunoperoxidase monolayer assay (IPMA),
was initially created for use in pigs37 and has been adapted for commercial use in horses;
a newer version of the IPMA is also commercially available as it reportedly has less
background staining artifact, although no manuscripts detailing its use have been
published. Outside of the United States, a blocking ELISA is commercially available for
use in horses, while a newly equine-validated ELISA20 is currently available in the U.S.
on a research and limited commercial basis. With the exception of the blocking ELISA
available outside of the U.S., serologic tests appear to be highly specific for L.
intracellularis exposure.38 It is important to note that these tests detect whole
immunoglobulin (IgG) to the bacterium, which is a result of exposure and not indicative
of clinical EPE or ongoing infection. Further, individual horses respond differently to L.
intracellularis exposure and the severity of exposure and infection cannot, as of yet, be
inferred from the titer value obtained. Based on experimental studies, horses challenged
with L. intracellularis have been shown to seroconvert within 14 days of challenge while
most begin showing clinical signs of EPE by day 19-21.10,39 These horses were
administered doses likely far in excess of that which is normally encountered, which may
have decreased the incubation period of the disease.
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Pathological/Post-mortem Features of EPE
The pathological features of EPE and PPE typically identified on post-mortem
examination of affected animals are fairly similar, namely small intestinal mucosal
hyperplasia. L. intracellularis in horses is most commonly identified in enterocytes of
the terminal ileum, immediately prior to the ileo-cecal junction. Intestinal mucosal
hyperplasia is typically found in this region, and results from rapid and unchecked
division of the crypt cells. Histologically, these regions exhibit crypt epithelial
hyperplasia with subsequent elongation and branching of the crypts and villi, a decreased
goblet cell density,1 and typically a lack of evidence of a cellular inflammatory process
(except in PHE and N-EPE cases where the inflammation is likely secondary to mucosal
necrosis9).1
Though mucosal proliferation is a hallmark of this disease, the underlying
mechanism remains unknown. Several possible mechanisms for L. intracellularis
virulence have been proposed including perturbations in cell cycle processes of crypt
epithelia, alterations of factors involved in the differentiation of normally immature and
proliferative crypt cells, disturbances of relevant growth factor receptors, and failure of
apoptotic cell death in the crypt.40,41 A recent study examined the effect on differential
expression of cell cycle and cell differentiation genes within mouse fibroblast cells
infected with L. intracellularis.41 While this led to the identification of a large number of
candidate genes potentially responsible for the proliferation and hyperplasia seen with L.
intracellularis infection, mouse fibroblasts are not typically affected by L. intracellularis.
Genomic sequencing studies have recently identified the genes for and expression of type
III secretion system components by L. intracellularis.42,43 This finding is important as
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type III secretion systems in other enteric pathogens have been shown to contribute to
apoptosis perturbations, cellular invasion, and immune suppression.42

Epidemiology of EPE
To date, the epidemiology of EPE remains poorly characterized, although a fecaloral route of transmission is widely suspected.30 With EPE, the most commonly affected
age groups are weanling and short yearling horses (those yearlings that have not yet
reached 12 months of age),11,20 although there are unpublished reports of rare cases in
nursing foals and older horses. Recent work has suggested a possible role for rabbits in
the transmission of the bacterium as several weanling horses were nasogastrically
intubated with feces from experimentally challenged rabbits, ultimately leading to
seroconversion but no disease in the study horses.44 Further, a non-challenged sentinel
horse that was co-housed with an experimentally challenged horse seroconverted during
another study, but again, no signs of EPE were noted.39 Several studies have revealed the
presence of L. intracellularis in a variety of species, including blacktailed jackrabbits,
cottontailed rabbits, cats, striped skunks, Virginia opossums, coyotes, guinea pigs, mice,
rats, hamsters, hedgehogs, ferrets, rabbits, wild pigs, dogs, foxes, calves, wolves, deer,
ostriches, emus, monkeys, and giraffes;1,45-47 however, none have been successfully
implicated in the induction of EPE. Although there is recent evidence of speciesspecificity with respect to L. intracellularis strains,48 a role for rodents, rats in particular,
warrants further investigation in the future as work has shown a proportion of rats on
PPE-endemic farms can shed up to 1010 L. intracellularis organisms per gram of feces.49
This is of particular importance as experimental challenge studies in pigs have induced
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PPE at bacterial doses as low as 105 per pig50 while EPE has been induced in using doses
of 1010 per horse.10,39 Further, one study has shown that the bacterium may be capable of
infectivity up to two weeks in the environment at temperatures of 5-15oC,51 raising the
possibility of a prolonged period during which there is a risk of exposure.
Due to the significant impact of L. intracellularis on the swine industry, progress
in understanding PPE epidemiology is much more evolved than it is with EPE. It has
been hypothesized that PPE persists and is transmitted within swine operations via
poor/inadequate disinfection techniques as well as subclinical shedders of the bacterium.
Indeed, work has shown that subclinically affected pigs can efficiently spread the
bacterium amongst cohorts.52 Although a study with bi-monthly fecal PCR testing did
identify several weanling horses that shed the bacterium in the absence of clinical signs,19
the role, if any, subclinically affected horses play in transmission remains to be
determined, especially given the management differences between swine and equine
operations. Sows are not believed to play a role in the transmission of the bacterium to
their offspring, although they have been reported to occasionally shed the bacterium.53
The possibility that mares could be exposing their foals to L. intracellularis is explored in
Chapter 4.

Prevention/Mitigation of EPE
A licensed and effective vaccine for the prevention of PPE exists in the United
States (Enterisol Ileitis, Boehringer Ingelheim Vetmedica).54-56 Off-label research into
the use of the porcine vaccine in horses has garnered mixed results with a small-scale
experimental challenge study suggesting that the vaccine protects against clinical EPE57
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while a field trial identified at least one vaccinated horse with clinical EPE.58 Anecdotal
reports from equine veterinarians in central Kentucky with experience using the vaccine
off-label suggest a decrease in the incidence of EPE on those farms that elect to utilize it.
As with any enteric disease, and especially given the suspected feco-oral
transmission route and suggestion of horse-to-horse exposure, it seems prudent that those
horses with suspected or confirmed EPE be isolated for a week following initiation of
antimicrobial treatment to allow time for fecal shedding to cease.30 Work with pigs
suggests that quarantine is an effective mechanism of preventing PPE,59 however, given
the open nature of equine farms, as well as the potential for wildlife hosts/intermediaries,
it seems unlikely that additional quarantine of new horses above what is routinely done
would have a beneficial effect on the disease incidence.
The use of a regular screening program to detect L. intracellularis exposure and
early EPE has been reported to be useful in the mitigation of EPE19 and variations on
these programs are used on some EPE-endemic farms in central Kentucky. These
screening programs typically include weekly screening of total protein levels for
abnormally low levels; those horses with low levels are then monitored closely for signs
of EPE and may have additional diagnostic tests run, such as albumin determination,
abdominal ultrasonography, fecal PCR, and/or serological testing. Given the nonspecific nature of total protein and albumin level fluctuations, it is never recommended to
treat horses with antimicrobials for suspected EPE based solely on these parameters.
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Section II: Lawsonia intracellularis and Immunology

Immune Response to Lawsonia intracellularis
Given the intracellular nature of L. intracellularis, it is likely that innate and cellmediated immunity is more important than humoral immunity with respect to clearance
of the bacterium from infected animals. While antibodies provide an excellent,
antemortem indicator of exposure to L. intracellularis,20,37 their role in the prevention or
clearance of L. intracellularis remains unclear. This review will therefore focus on the
innate and, primarily, cell-mediated branches of the immune system.
The uptake of L. intracellularis into enterocytes appears to be via endocytosis.60
Typically, this bacterium-containing endosome would fuse with a lysosome in the hostcell cytosol for degradation and antigen processing; however, L. intracellularis, by an
unknown mechanism, evades this process and is reportedly found free in the enterocyte
cytoplasm within three hours of invasion.61 Throughout this process, and as evidenced
by the typical lack of an inflammatory response to L. intracellularis,1 the bacterium
seems to evade the innate immune system in the gastrointestinal tract.
Innate immunity exists to quickly detect and respond to non-self antigens
expressed by a large variety of pathogens, including bacteria, viruses, and fungi. By
doing so, the innate immune system bridges the gap in time between pathogen
presentation/invasion and the acquired cell-mediated and humoral immune responses.
The innate immune system relies on highly conserved molecular signatures on pathogens,
generally referred to as pathogen-associated molecular patterns (PAMP's), including but
not limited to lipopolysaccharide (LPS), peptidoglycan, flagellin, DNA, and RNA.62
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Most PAMP recognition by host cells is carried out via detection by either toll-like
receptors (TLRs) or nucleotide-binding oligomerization domain receptors (NOD-like
receptors or NLRs). Of the various TLRs and NLRs which have been identified and
characterized, the most important with respect to L. intracellularis based on their location
and function likely would be TLR4, TLR5, Nlrc4, and Nlrp3.62,63
Immediately prior to and during invasion, L. intracellularis, a gram-negative,
flagellated bacterium, must evade detection by TLR's 4 and 5. Both are located on the
outer surface of enterocytes where TLR4 is specific for LPS and TLR5 is specific for
flagellin.62 Likewise, once free within the enterocyte cytoplasm, L. intracellularis
evades intracellular Nlrc4 (detects flagellin) and Nlrp3 (detects bacterial RNA and
LPS).63 Normally, once bound to their respective ligands, both TLRs and NLRs induce a
pro-inflammatory response as TLRs will induce NF-κB via the MyD88 pathway and
NLRs activate caspase-1, leading to the conversion of pro-IL-1β to IL-1β. Interestingly,
TLR4 has been suggested to play a role in the occurrence and severity of necrotizing
enterocolitis in mice and humans.64,65 Given that PHE and N-EPE are characterized by
mucosal necrosis while other forms of L. intracellularis infection are relatively devoid of
an inflammatory response,1 it stands to reason that "accidental" detection of the bacterium
by either the TLRs or NLRs could be the cause of these severe outcomes.
Similarly, it would be expected that the cell-mediated immune system should play
a significant role in immunity to L. intracellularis. The host's response to a pathogen via
cell-mediated immunity (CMI) depends on whether that response is weighted in favor of
T-helper 1 cells (Th1) or T-helper 2 cells (Th2).66 T-helper cells are CD4+ with an
affinity for major histocompatability complex II (MHC-II), primarily located on the
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surface of antigen presenting cells and B lymphocytes. While initially present as
undifferentiated T-helper 0 cells (Th0), whether these cells differentiate into Th1 and Th2
cells is dependent upon the cytokines present in the local environment.66 In turn, the
cytokines produced depend on the type and location (intra- vs. extracellular) of the
pathogen of interest. Another type of T-helper cell, the regulatory T cell (Treg), is
important for immune-modulation and suppression.67 Tregs do this by migrating to sites
of inflammation and suppressing lymphocytes, with T-helper cells being the main
target.67 Further, Tregs can be induced in tissues by cytokines, such as TGF-β.67 Given
recent work suggesting an increase in TGF-β production by enterocytes when infected
with L. intracellularis,68 as well as the lack of inflammation during typical L.
intracellularis infections,1 it seems feasible that L. intracellularis may utilize Tregs to
prevent overwhelming inflammatory reactions in response to enterocyte infection.
With L. intracellularis, we are primarily interested in the Th1 response targeted
towards CMI and killing of intracellular organisms. Th2 responses are targeted towards a
humoral response and antibody production for the killing of extracellular organisms. Th1
cells are produced in response to the presence of interleukin (IL) 2, IL-12, IL-18,
interferon-gamma (IFN-γ), and tumor necrosis factor alpha (TNF-α); Th2 cells are
produced due to the presence of IL-4, IL-5, IL-10, IL-13, and IL-β.69 Pathways taken by
Th0 cells depend on cytokines from antigen presenting cells, either as a result of infection
or antigen processing. Once a Th0 differentiates into a Th1 or Th2 cell, this process
typically continues with the recruitment of other nearby, antigen-specific Th0 cells as the
newly differentiated T-helper cells release more cytokines that potentiate their
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differentiation while inhibiting that of the other T-helper subtype.66 Thus, once an
immune response begins on Th1 or Th2 paths, it typically continues in that fashion.
Multiple studies have detailed the induction of a CMI response to L.
intracellularis infection. This has primarily been done in experimentally infected pigs
through L. intracellularis-stimulation of peripheral blood mononuclear cells (PBMCs) in
vitro where an increase in IFN-γ production was noted as soon as 14 days postinoculation with either a pathogenic or vaccine strain of the bacterium.70 This increased
production of IFN-γ in vitro can be augmented by co-culture of PBMCs in the presence
of IL-18.71 Additionally, a recent study utilizing a commercially available vaccine
showed that pigs vaccinated orally had significantly more TNF-α in small intestinal
mucosal scrapings when compared to non-vaccinated and intramuscularly vaccinated
controls, further suggesting a Th1 response to bacterial colonization.68 More germane to
this review with regards to equids is the recent study that found PBMCs from L.
intracellularis vaccinated and naturally occurring EPE horses produced increased
amounts of IFN-γ mRNA in vitro when stimulated with the bacterium when compared to
non-exposed controls.72 Further, vaccinated horses demonstrated an increased level of
mRNA expression through the study's termination at 180 days post-vaccination,
suggesting a long-lived memory recall with a Th1 bias.72 Interestingly, the amount of
IFN-γ mRNA produced in response to the bacterium did not differ significantly between
the vaccinated and EPE horses. Given that primary infection with L. intracellularis
protects against repeat colonization in pigs,50,73 vaccination of equids might provide
protection against disease. Except for what is presented in Chapter 5, the role of IFN-γ
on the occurrence of PE in pigs and horses has not been reported.
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The best evidence for a significant role of IFN-γ in infection and immunity to L.
intracellularis comes from studies using knockout mice. Smith et al. 2000, showed that
IFN-γ knockout mice developed more severe disease than wild-type mice of the same
genetic background.74 This increased severity, compared to controls, manifested as a
higher enterocyte infection rate, increased mucosal hyperplasia (small intestine and
colonic), and a failure to clear the infection in 35 days.74 While the control group in this
study did develop disease, the infection was cleared by day 28 post-challenge. The
decreased amount of hyperplasia compared to the knockout group confirmed a previously
reported75 anti-proliferative role for IFN-γ in enterocytes.74 An additional Short
Communication provided some evidence of high levels of systemic IFN-γ in receptor
knockout mice (severely afflicted with disease) compared to wild-type (and diseaseunaffected) controls, a finding the authors interpreted as indicating IFN-γ binding is
vitally important to prevention of L. intracellularis-induced disease.76
The Th1 response to intracellular infection, mediated in large part by IFN-γ,
generally functions to increase inflammation at the site of infection, as well as activate
macrophages and increase cytotoxicity mediated by CD8+ cytotoxic lymphocytes (CTLs).
Given the lack of an inflammatory response during normal L. intracellularis infections,1
much like with the innate immune system, the bacterium seems to largely avoid the cellmediated immune response in affected animals. One possible explanation for this would
be the presence of an immature or incompetent Th1 response in those animals that are
affected with L. intracellularis. While recent work with foals has detailed many
interesting findings supporting this assertion, little work has been conducted in the age
group we are interested in, weanlings and young yearlings.
27

It has now been shown that, like human neonates,77 neonatal foals are lacking in
their ability to produce IFN-γ early in life.78 Even though the deficiency does abate
quickly and a rapid maturation in the ability to produce IFN-γ is seen, it can take 10
months or longer for the percentage of IFN-γ positive lymphocytes and the production of
in vitro IFN-γ to approach that of adult horses.78 Interestingly, recent work in our lab
showed that foal exposure to a barn atmosphere, which contained significantly more
aerosolized fungi and bacteria compared to pasture, was associated with a significantly
increased number of IFN-γ positive lymphocytes compared to those foals housed solely
on pasture.79 While the finding that the environment can have a profound impact on CMI
may be important with respect to a variety of young horse diseases, the effect only lasted
through 3 months of age, so the potential significance with respect to L. intracellularis is
unclear given that these horses are typically weaned at 4-6 months of age. The process of
weaning itself has been hypothesized as one of the reasons weanlings are predisposed to
L. intracellularis infection.11 Recently it was shown that weaning can have a detrimental,
albeit short, effect on IFN-γ production where abruptly weaned horses exhibited a rapid
(within 7 days post-weaning) decrease in IFN-γ positive lymphocytes and IFN-γ mRNA
expression which lasted until at least 14 days post-weaning.80 It was hypothesized that
this decrease was caused by stress-induced hormones, so while very few horses exhibit
clinical EPE in the weeks following weaning (see Chapter 3 below), it is possible that
stressful events in the months following weaning may exhibit the same pattern and lead
to L. intracellularis susceptibility. Along these lines, the closest "relatives" of L.
intracellularis, the Desulfovibrio genus, has some species which may exhibit
opportunistic infection patterns.81
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While the mechanism(s) by which L. intracellularis escapes the immune system
remains unknown, some work has indicated that the bacterium exerts an
immunosuppressant effect on the small intestine of pigs.82 The suggested
immunosuppressant effect of L. intracellularis, in addition to the identification of a Type
III secretory system which is known to be immunosuppressive in other enteric
organisms,42 involves a substantial decrease in small intestinal T (primarily CD8+) and B
cells, as well as MHC II expression, within 14 days of challenge with the bacterium.82
Interestingly, in vitro work using PBMCs from PPE cases has showed the opposite
occurs, with an increase in lymphocyte proliferation due to stimulation with the
bacterium.83 The finding that CD8+ cell numbers are decreased in vivo is important
because, although the study had no negative controls for comparison, CD8+ CTLs from
infected pigs have been shown to produce large amounts of IFN-γ following in vitro
stimulation with L. intracellularis.84 Work with humans has also shown that MHC IIrestricted CTLs play an important role in enterocyte immunity,85 and CD8+ MHC IIrestricted T cells have been identified in pigs and horses.86,87 Though another L.
intracellularis study showed CD8+ CTLs produced lower quantities of IFN-γ than Th1
cells,71 a decrease in CD8+ cells within the small intestine following infection with L.
intracellularis would be accompanied by a reduced IFN-γ response, possibly contributing
to the immune evasion of the bacterium. Additionally, a concurrent decrease of MHC II
expression both in the lamina propria82 and on the enterocyte surface86 following L.
intracellularis infection would further assist the bacterium with evasion.
As mentioned previously, both vaccination and prior clinical disease have been
shown to prevent secondary disease caused by L. intracellularis.50,54,68,73 Disease in pigs
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has been reportedly induced using doses of 105-1010 organisms/animal, and while there
appears to be a dose-dependent severity of disease, 50 all of the doses protected pigs from
re-infection (not just clinical disease) when later re-challenged at 1010
organisms/animal.50 Due to the solely enteric nature of L. intracellularis infections, all
protective measures have been enterically-targeted, through either the use of oral54 or
intra-rectal88 vaccination. A recent paper, however, has suggested that intramuscular
(IM) vaccination with the commercially available vaccine was as protective as the
traditional oral route for vaccination in pigs.68 Given that IM vaccination would be
unlikely to induce mucosal immunity and that elevated IgG serum titers resulted, IgG
may confer possible protection against infection.68 However, another recent report
suggested that maternal IgG in piglets (explored with respect to EPE in Chapter 3) had no
protective effect against disease, although it was a secondary parameter that was not
examined in depth.84 While the role, if any, IgG plays in infection and immunity to L.
intracellularis remains unresolved, the role of the humoral system has been examined in
several papers. It has been widely reported that systemic IgG production occurs in
response to natural infection and re-infection/challenge with L. intracellularis in both
pigs and horses,11,20,50,88 although IgG detection in vaccinated animals is variable.68,88 It
appears as though the detectable humoral response occurs faster than a detectable CMI
response89 and the magnitude and duration of detectable IgG titers is dose-dependent in
pigs.50
Unlike IgG, due to the enteric location of L. intracellularis, it seems likely that
IgA would play a role in infection and immunity to the bacterium. Indeed, work has
shown that IgA accumulates in infected enterocytes.86 Although whether this was a
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bacterium-specific accumulation or due to an effect of the bacterium on IgA passage
through the infected enterocyte was not elucidated, it has been suggested that IgA may
play a role in neutralizing intracellular organisms as it passes through infected
enterocytes.90 L. intracellularis-specific IgA has been reported in the small intestinal
lumen within 22 days post-infection89 although other studies have been unable to detect
significant amounts of specific IgA in either the small intestine or serum following
vaccination;68 whether this would be due to a dose or strain difference is unknown.
Our overall hypothesis is that the host immune response plays a significant role in
the susceptibility of weanlings to L. intracellularis infection and the occurrence of equine
proliferative enteropathy. The large number of horses, particularly Thoroughbreds,
around the central Kentucky region have provided an opportunity to study this relatively
rare disease at a rate that is likely higher than elsewhere in North America. The specific
aims of the following studies are to :
1. Develop and validate an ELISA for the detection of L. intracellularis-specific
antibodies and then use this ELISA to determine whether previous farm history of
EPE has an effect on seroprevalence (Chapter 2).
2. Determine whether passively-acquired antibodies have an effect on the
susceptibility to L. intracellularis and the occurrence of EPE (Chapter 3).
3. Evaluate whether mares play a role in the epidemiology of EPE on endemic farms
using mare serological status (Chapter 4).
4. Determine whether L. intracellularis-specific IFN-γ expression is associated with
resistance to EPE (Chapter 5).
Copyright © Allen Edward Page 2013
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CHAPTER TWO:
Adaptation and validation of a bacteria-specific enzyme-linked
immunosorbent assay for determination of farm-specific Lawsonia intracellularis
seroprevalence in central Kentucky Thoroughbreds

Summary

Lawsonia intracellularis is the causative agent of equine proliferative enteropathy
(EPE), a bacterium for which no large-scale seroprevalence studies have been conducted.
The objectives of this study were to validate and use an equine-specific ELISA for L.
intracellularis to determine the seroprevalence of L. intracellularis on numerous farms
and the effect of past EPE history on seroprevalence. An ELISA was adapted from
previous work in swine to use purified antigen. A total of 337 Thoroughbreds from 25
central Kentucky farms were enrolled and monthly serum samples collected from August
2010 to January/February 2011. Samples were screened for L. intracellularis-specific
antibodies using a modified ELISA. Farms were classified into one of three groups based
on their recent (in the three years prior to the study) history with EPE. The overall
ELISA intra-assay coefficient of variation (CV) was 6.73 and inter-assay CV was 9.60.
An overall seroprevalence of 68% was obtained, with farm specific seroprevalences
ranging from 14-100%. A significant difference was found in the average seroprevalence
(p<0.05) on farms with recently presumptive cases of EPE. Additionally, both lower
average ELISA unit (EU) values (p=0.079) and maximum EU values (p=0.056) on farms
with no recent EPE history were detected when compared with farms with recently
presumptive or suspected cases of EPE. Further, a bimodal exposure distribution to L.
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intracellularis was detected in the fall and winter months. With this work, we showed
that recent history of EPE was associated with higher average seroprevalence indicating
increased exposure on farms with prior cases of EPE; seasonally bimodal exposure was
also observed. The adapted ELISA appears to be useful for determination of L.
intracellularis-specific antibody levels. The high farm-specific seroprevalences and
bimodal distribution of exposure to L. intracellularis detected here were unexpected and
suggest that farms with a previous history of EPE remain at risk due to heightened
exposure levels beyond early winter.
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Introduction

Lawsonia intracellularis, an obligate intracellular, gram-negative rod, is the
causative agent of proliferative enteropathy.1 L. intracellularis is viewed as an emerging
cause of proliferative enteropathy in a variety of mammalian species,91,92 including
horses,14,93-95 where the bacteria causes equine proliferative enteropathy (EPE).
Clinical signs of EPE, usually seen in weanlings or young yearlings,11,18,94-96 include
anorexia, fever, lethargy, depression, dependent edema caused by
hypoproteinemia/hypoalbuminemia, weight loss, colic, and diarrhea. In addition,
thickened small intestine detected by abdominal ultrasound is considered highly
suggestive of EPE when accompanied by compatible clinical signs. Commercially
available antemortem tests for EPE include fecal L. intracellularis-specific PCR and the
serum immunoperoxidase monolayer assay (IPMA), both of which have been adapted
from their use in pigs where the tests are highly specific; sensitivity is reported to be high
for the IPMA37,53 but variable for fecal PCR.32,34
Though the epidemiology of EPE is uncertain, it is believed that transmission
occurs through the ingestion of L. intracellularis-contaminated fecal material from wild
or domestic animals.46 While most cases of EPE typically occur in the fall and early
winter,11,19 the reason for this seasonal predilection has not yet been determined. One
possibility is the known susceptibility of weanlings to this infection and weaning
typically occurs during this time of year.11 Another possibility would be that the
environmental conditions at that time favor transmission by increasing exposure burdens.
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Previous work looking at L. intracellularis-specific antibodies demonstrated
seroprevalences ranging from 33.8-45.5% on two California farms97 and up to 60% on a
Kentucky farm,19 utilizing the IPMA method. While these studies have focused on
individual farms, none have determined the seroprevalence of L. intracellularis within a
larger region. Detection of L. intracellularis-specific antibodies using enzyme-linked
immunosorbent assays have been developed for the pig and rabbit.98-101 Here we adapted
a porcine ELISA99 and used this ELISA method to determine seroprevalences on
Thoroughbreds farms located in central Kentucky.
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Materials and Methods

Farm selection and information gathering
A total of 25 Thoroughbred farms were recruited for participation in this study
using various methods, including a presentation to the local farm managers club as well
as emails and phone calls to local farm managers. The only requirements for inclusion
were that the farm population of horses be 75% or greater Thoroughbreds and that the
farm be located within a 25 mile radius of Lexington, Kentucky. Consent for inclusion of
privately-owned horses was obtained from the farm managers, who were authorized to
act on the behalf of any private owners.
After inclusion in the study, farms were asked to provide information regarding
EPE cases in the preceding three years leading up to the study period. These data were
used to classify farms as having presumptive cases of EPE, suspected cases of EPE, or no
recent cases of EPE. Farms were considered to have had presumptive EPE cases if they
had one or more weanlings with clinical signs compatible with EPE, hypoproteinemia
and hypoalbuminemia, and either a concurrent positive fecal PCR or serum IPMA titer
result (1:60 or greater) in the preceding three years. For the purpose of this study,
compatible clinical signs for EPE were anorexia, fever, lethargy, depression, dependent
edema, rapid weight loss, colic, and diarrhea. Farms were considered to have had
suspected EPE cases if they had one or more weanlings with signs compatible with EPE,
but neither a positive fecal PCR nor positive serum IPMA titer result (1:60 or greater).
Farms were considered to have had no recent history of EPE if they experienced no
horses with clinical signs of EPE within the preceding three years.
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After the conclusion of the study, all participating farms were requested to
complete a questionnaire regarding EPE cases on the farm during the study period.
Based on this information, farms were classified for the study period into the three
categories as above.

Study Period
The study began August 16th, 2010 and was to conclude January 5th, 2011. For
some farms, an optional sample collection period from January 31st to February 2nd, 2011
was included in the study due to a large increase in the number of seropositive samples in
January. Samples were collected once during a three day period every four weeks from
the farms.

Horses
While some farms housed non-Thoroughbred horses, only Thoroughbred horses
were included in the study. All horses in the study were born during the 2010 foaling
season and were weaned by November 2010. Farms were requested to provide a list of
all 2010 horses present on the farm in early-August 2010. If a farm had fifteen or fewer
2010 horses at this time, all horses were included in the study. For those farms with 16 or
more horses present in early-August, 15 horses were chosen randomly to participate
(except for farm 19, from which all 16 horses were included in the study at the farm’s
request). Randomization was achieved by assigning each horse a sequential number and
utilizing a random number generatorA to select the 15 horses for inclusion in the study.

A

Microsoft Excel, Microsoft Corporation, Redman, WA
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Each horse included in the study was assigned a unique three-digit identification number
for ease of results tracking, as well as maintaining anonymity.

Sample collection and handling
Once every four weeks, a 10ml sample of whole blood was collected into
individually labeled, sterile, red-top 10ml blood tubes via jugular venipuncture. Samples
were submitted and held at centralized laboratories at 4oC for less than 24hrs before they
were collected and transported to the Maxwell H. Gluck Equine Research Center at the
University of Kentucky. Upon arrival, samples were immediately centrifuged at 800xg
for 10 min. Serum was transferred to tubes labeled with the month and the unique threedigit code assigned to its horse and frozen at -20oC until analyzed.
For various reasons, including public sale, private sale, or a horse being returned
to its owner, a number of blood samples were omitted from the study. As such, any
horses that left the study prior to November were completely excluded from the data set.
Horses remained in the study even if one or more samples were not collected after
October.
Serum samples obtained from six Lawsonia intracellularis-challenged weanlings
and 15 uninfected controls were included for the validation of the ELISA, with
information regarding the challenge reported elsewhere.10

Lawsonia intracellularis-specific immunoperoxidase monolayer assay
The IPMA method for determining L. intracellularis-specific antibody titers was
performed as previously described.37
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Purification of L. intracellularis
Porcine-origin L. intracellularis was obtained from cell culture6 and purified
using DEAE column chromatography which allowed the bacterium to be eluted as a
whole organism. The presence of L. intracellularis in the eluate was verified
microscopically using Gimenez stain, in addition to PCR for L. intracellularis, as
previously described.102 Additionally, no other bacteria were detected following aerobic
and anaerobic culture, as well as Gram staining. The pooled purified bacterial eluate with
sodium azide was kept refrigerated (4oC). Quantification of the purified, wholebacterium was performed using the BCA method.103

Lawsonia intracellularis-specific enzyme-linked immunosorbent assay
The ELISA was based on a previously described method99 with respect to
starting concentrations of reagents and a checkerboard titration scheme, as described
elsewhere.98,99 Factors influencing background were minimized using previously
described methods.99 From this, it was found that serum dilutions of 1:100 produced the
most consistent results with minimal background. Further, based on this approach, the
optimum concentration of antigen was 2.5µg/mL and the use of a polyvinyl alcohol block
was superior to 5 or 10% skim milk.
The ELISA plates wells B were coated with 2.5µg/ml of purified L. intracellularis
in carbonate buffer C, then covered with Parafilm-M D and allowed to sit overnight at 4oC.

B
C

Immunolon 1b Flat Bottom Microtiter Plates, Thermo Scientific, Rochester, NY
Sigma Aldrich, St. Louis, MO
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After plates incubated overnight, they were washed three times with phosphate-buffered
saline with 0.05% Tween-20 E (PBST) using an ELISA plate washer F. The coated plates
were then blotted dry before adding 200µl/well of blocking buffer (polyvinyl alcoholG
1% (w/v) in distilled water) for two hours at room temperature. After blocking, the plates
were washed three times, as above. Sera were diluted at 1:100 in blocking buffer and
added (100 µl) to duplicate wells. Plates were then incubated at room temperature for 1
hour. Duplicate, serially diluted (1:60 through 1:3840) serum samples from a weanling
exhibiting clinical signs compatible with EPE, including anorexia, weight loss, and
dependent edema, were used to generate a standard curve. This weanling tested positive
repeatedly at 1:1920 using the IPMA method. Negative control samples included serum
from repeatedly L. intracellularis antibody-negative weanlings along with a duplicate
sample of 100µl fetal equine serum diluted 1:100. After 1 hour incubation with diluted
test and control sera, the plate was washed three times and 100µl of murine anti-horse
IgG (1:4000) conjugated with horseradish peroxidase H (HRP) was added to each well.
The plate was then incubated in the dark for 1 hour at room temperature before being
washed three times. To each well was then added 100µl of 3,3’,5,5’-tetramethylbenzidine (TMB) solution I for two minutes before the reaction was stopped with
TMB Stop solution J. Absorbance at 450nm was read within 5 minutes using an ELISA

D

Bennis Flexible Packaging, Neehah, WI
Sigma Aldrich, St. Louis, MO
F
MW 96/384, Beckman Coulter, Brea, CA
G
Mowiol 6-98, Sigma Aldrich, St. Louis, MO
H
Sigma Aldrich, St. Louis, MO
I
SureBlue™ TMB Microwell Peroxidase Substrate, KPL, Gaithersburg, MD
J
KP, Gaithersburg, MD
E
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plate reader K. Results from the test sera were converted to an ELISA unit (EU) utilizing
a linear trend line from the standard curve generated from each plate. A coefficient of
determination (r2) of ≥.90 was required for the plate to be considered valid.98
A positive cut-off of 55EU or greater was utilized based on non-challenged
weanlings having an average of 33EU’s and a standard deviation of 7EU’s;10 these
samples repeatedly tested negative via IPMA. By setting the cut off at 55EU’s, this value
is three standard deviation units above the negative control averages and represents the
upper limit of a 99% confidence interval.

Evaluation of assay repeatability
Twenty-four samples were selected for the ELISA repeatability test. These
represented a variety of negative (<55EU), low (55-119EU), mid (120-239EU), and high
(≥240EU) samples. For intra-assay repeatability, three replicates of each sample were
performed on the same plate. For inter-assay repeatability, three replicates of each
sample were run on duplicate plates on different days. Coefficient of variation (CV =
SD/mean x100%) of the three replicates from each test were evaluated. In addition, CV’s
of the standard curve ODs from each plate was evaluated.

Data analysis
Farms 8 and 9 were ultimately considered as one farm data set since the horses
from these two farms were combined into one population once the foals were weaned.
Likewise, Farms 22 and 23 were combined into one data set for the same reason.

K

Benchmark Plus, Bio-Rad, Philadelphia, PA
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One-way analysis of variance (ANOVA) (Holm-Sidak method L) was used to evaluate
differences in ELISA unit values between farms categorized based on their past EPE
status. Post hoc t-tests were performed to evaluate the differences between groups. Chisquare analyses were used to assess seroprevalence results. Calculated P values <0.05
were considered to be statistically significant.

L

SigmaStat, SPSS Inc., Chicago, IL
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Results

In order to validate our ELISA, serum samples of varying EU’s were run in
triplicate with an overall intra-assay CV of 6.73 and inter-assay CV of 9.60. For the
standard curve, CV’s ranged from 2.08 to 7.69 with a mean of 4.85 and the most dilute
sample (1:3840 dilution) had the highest CV. Additionally, ELISA analysis of serial
serum samples from L. intracellularis-challenged weanlings demonstrated
seroconversion on or before day 20 post-challenge with all weanlings obtaining EU’s >
120 and a maximum of 746 EU while all non-challenged weanlings remained below 55
EU’s.10 Appendix I is provided to illustrate the relationship between OD and EU values
for the standard curve, which is run on every ELISA plate and used to calculate EU
values of unknown samples.
Provided in Figure 2.1 are all EU results for non-challenged controls and all
positive values from experimentally challenged weanlings,10 as well as clinically affected
field cases from the study period (EU values shown are those found at the initial time of
presentation). Clinically EPE affected weanlings demonstrated similar, and in some
cases greater, serum antibody levels against L. intracellularis when compared with
experimentally challenged weanlings. Figure 2.2 includes EU results from all horses in
the present study divided into two groups; study horses that failed to seroconvert
(<55EU) during the study and study horses that seroconverted (≥55EU) at any point
during the study period but failed to show clinical signs of EPE. A number of the nonclinical, seropositive horses exhibited very high EUs.
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Figure 2.1: ELISA Unit (EU) values for non-challenged weanling controls, L.
intracellularis-challenged weanlings, and clinical EPE cases. Dashed bar represents
55EU, the cut-off for positive samples.
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Figure 2.2: All study time points from those weanlings that remained seronegative
(<55EU) for the entire study and those that seroconverted at any point (≥55EU)
during the study period. Each column for the study horses represents an individual
horse. Dashed bar represents 55EU.
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Overall, a total of 337 horses were included in the seroprevalence data set as they
were present on the farms through at least November 2010. Of these 337 horses, a total
of 229 horses, or 68.0% of the study population, tested positive (≥55 EU’s) for L.
intracellularis-specific antibodies via the ELISA at one or more time points. The
monthly percentage of previously seronegative horses that seroconverted during a given
month and the accruing totals are shown in Figure 2.3. Overall there was a steady
increase in the number of seropositive horses over time with marked increases in monthly
seroconversion during October 2010 and January 2011. As shown in Figure 2.4, the
majority of the seropositive animals for a given month had EU values in the range of 55119EU. Beginning in October, one sees an increase in the frequency of high antibody
levels (>120 EU) paralleling the increase in seroconversions noted in Figure 2.3.
Serological results from individual farms including past EPE status of the farm,
EPE status during the study period, and calculated seroprevalence for L. intracellularis
are shown in Table 2.1. A total of 8 farms experienced presumptive cases of EPE during
the study period and no farms had suspected cases. Seven of these farms had already
been classified as recently experiencing presumptive cases of EPE and one had
previously experienced suspected cases of EPE. Farms without a recent history of EPE
experienced no cases during the study period. Calculated farm-specific seroprevalences
ranged from 14.3% to 100%. Figure 2.5 shows the average monthly seroconversion rate
grouped by recent EPE history. While those farms with a recent history of EPE
(presumptive or suspected) had some horses seroconvert each month, the farms with no
recent history of EPE (none) had several months where zero or only one horse
seroconverted. Table 2.2 shows the overall average seroprevalence as well as the average

46

positive and maximum EU values obtained from farms grouped by recent EPE status.
Those farms with a presumptive history of EPE had significantly (p<0.001) higher
average seroprevalences compared to those with suspected or no recent cases of EPE.
Additionally, the average EU (p=0.079) and average maximum EU values (p=0.056)
were found to be lower on farms with no recent history of EPE cases compared to the
other groups. Moreover, the range of maximum EU values is much smaller for the farms
with no recent EPE cases.
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Figure 2.3: The percentage of previously seronegative horses that seroconverted (55EU or greater) during a given month as
well as the cumulative number of seropositive horses.
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Figure 2.4: The monthly distribution of positive ELISA results reported as ranges of EU’s.

Table 2.1. Seroprevalence by farm according to previous EPE history and EPE
status during the study period. Farm-specific seroprevalences ranged from 14.3% to
100%.

Farm
1
2
3
4
5
6
7
8&9
10
11
12
13
14
15
16
17
18
19
20
21
22 & 23
24
25

History of
Previous
EPE Cases
No
Suspected
Presumptive
Presumptive
Presumptive
Presumptive
No
Presumptive
Presumptive
No
Presumptive
Suspected
Presumptive
Suspected
Presumptive
Presumptive
Presumptive
Presumptive
No
Presumptive
Presumptive
No
No

2010
Foaling
Season EPE
Cases
No
No
Presumptive
No
No
Presumptive
No
No
Presumptive
No
No
Presumptive
No
No
Presumptive
Presumptive
No
No
No
Presumptive
Presumptive
No
No

Total ELISA
Positive
Horses
11
3
9
7
10
9
2
16
9
10
5
13
9
9
11
14
15
12
2
11
24
10
8
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Total #
of
Horses
Sampled Seroprevalence
15
73.3%
15
20.0%
9
100%
12
58.3%
15
66.7%
10
90.0%
14
14.3%
26
61.5%
15
60.0%
15
66.7%
9
55.6%
15
86.7%
15
60.0%
15
60.0%
11
100%
15
93.3%
15
100%
16
75.0%
7
28.6%
14
78.6%
29
82.8%
15
66.7%
15
53.3%
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Figure 2.5: Monthly seroconversions for groups (presumptive, suspected, none) of farms based on recent EPE history.

Table 2.2. Average seroprevalence, positive EU’s, and maximum EU’s grouped by EPE history.
Previous EPE
Average
Cases
Seroprevalence
Presumptive
76.3%* (55.6-100%)
Suspected
55.6% (20-86.7%)
None
53.1% (14.3-73.3%)
#
*p<0.05; p<0.079; ##p<0.056

Average Positive EU
228.1 (85.5-378.9)
218.0 (59.7-326.2)
123.9# (59.5-175.6)

Average Max EU
1683.4 (193.8-4312.3)
1604.6 (62.2-3319.4)
453.9## (55.6-904.1)
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Discussion

Here we described the use of an ELISA method to characterize the serological
response of Thoroughbred weanlings to L. intracellularis on central Kentucky farms.
This ELISA used column chromatography purified, whole L. intracellularis, thus
optimizing reproducibility, as evidenced by an overall intra-assay CV of 6.73 and interassay CV of 9.60. Using this method, farm-specific seroprevalences ranged from 14.3 –
100%. As such, these results are comparable with a past screening study in the central
Kentucky region which used the IPMA method and showed an EPE endemic farm to
have a seroprevalence of approximately 60% while a non-endemic farm had a
seroprevalence of 17%.19
Not surprisingly, seroprevalences corresponded well with the past history of EPE
cases on the farm. Significant difference between groups based on recent EPE history
was seen with respect to average seroprevalence. Additionally, farms with no recent
clinical cases of EPE had both lower average EU and average maximum EU values for
their positive samples. One possible explanation is that farms with no history of EPE
cases likely had lower environmental burdens of L. intracellularis resulting in fewer
horses being exposed to the bacterium (lower seroprevalence) and less antigenic
stimulation per exposure (lower EU values). Evidence for this assertion is provided by
the non-endemic farm from a previous study,19 which is also represented in the current
study (Farm 15). While originally considered non-endemic, the farm has since reported
suspected cases of EPE and was re-classified for the purpose of this study. Accordingly,
the farm’s seroprevalence was found to be 60% with an average positive EU of 326.2 and
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a maximum EU of 3319.4. Given that the epidemiology of EPE remains poorly defined,
these data begin to indicate that relative burdens of L. intracellularis in the environment
may explain why certain farms have an endemic problem with EPE.
Monitoring of weanlings by the enrolled farms ultimately identified 8 farms with
presumptive cases of EPE during the study period from August 2010 through February
2011. Perhaps not surprisingly, these 8 farms represented only those with prior
presumptive or suspected cases of EPE (7 and 1, respectively). While definitive
antemortem diagnosis of EPE remains controversial, elevated L. intracellularis-specific
antibody levels are commonly seen in clinically affected horses.10,11 These presumptive
cases likewise exhibited an elevated antibody response, as was also detected in the L.
intracellularis-challenged weanlings,10 using this ELISA.
While previous reports from the central Kentucky region suggest a single peak
of exposure occurring during late-Fall/early-Winter,11,19 we provide new evidence of
bimodal exposure occurring both in the fall and winter. These results correspond directly
with anecdotal evidence indicating a large increase in the number of cases of EPE in this
area during the months of January and February 2011. The reason for this increased
incidence of EPE has yet to be elucidated. Possible explanations include changes in
weather patterns, changes in management, and increased exposure to the unknown
reservoir, which could include clinically or subclinically affected horses. With respect to
these possibilities, it should be noted that the summer and fall of 2010 experienced less
rainfall when compared with average amounts for the region. Additionally, there were
lower daily temperatures starting in November with increased amounts of both rain and
snow, beyond what is normal for central Kentucky during the early winter months.
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While the ELISA method affords ease of use and reliability, the establishment of
a cut-off value to separate negative and positive samples is critical. The current positive
cut-off (≥55EU) utilized the average EU plus three standard deviations from nonchallenged weanlings, reported elsewhere,10 and differentiated between known
seropositive and seronegative horses. Twelve field cases evaluated using the ELISA
demonstrated high levels of L. intracellularis-specific antibodies, equaling or surpassing
those EUs detected in experimentally challenged weanlings. Also noted were several
non-clinically affected weanlings with markedly elevated EU values. These could be
indicative of a successful immunological response to infection or a subclinical case that
was not detected by the farm; both situations were observed in the previous challenge
study.10 As such, these findings provide further evidence that the new ELISA
successfully detects antibodies to L. intracellularis in clinical and non-clinical horses.
There were two inherent limitations with the design of this study. First, there was
an over representation of farms with presumptive or suspected cases of EPE in the data
set. This likely reflected the fact that those farms with a prior history of what they
consider a frustrating disease were more willing to participate and provide data.
Additionally, the stigma associated with this disease in central Kentucky may have
contributed to the large number of farms that declined to participate due to fears that their
status with respect to L. intracellularis and EPE would become public. As such, the
overall seroprevalence of 68% should not be considered representative of the equine
population in this region without further, randomized sampling. Nevertheless, 20% of
the horses surveyed came from farms with no recent history of EPE and we reported both
farm-specific and group-specific seroprevalences. The other limitation and potential
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source for error revolves around the possibility of cross-reaction of this ELISA with other
bacteria. Phylogenetic studies have found that while L. intracellularis appears to be a
member of unique pathogens,104 more recent work has shown L. intracellularis shares
similarities with some rickettsial families.105 As such, potential cross-reactivity between
other potential organisms cannot be excluded without further testing. However, work to
validate the ELISA from which the method reported here was adapted failed to detect any
cross-reactivity between L. intracellularis and related bacterial species.99
By screening a large population of central Kentucky Thoroughbreds using a
newly validated and equine-adapted ELISA, a high seroprevalence for L. intracellularisspecific antibodies was detected with variable farm-specific seroprevalences. Previous
history of EPE on the farms was associated with significant differences in average
seroprevalence indicating lower levels of exposure are present on farms with no history
of EPE. Additionally, a bimodal, seasonal distribution of exposure was documented.
The high farm-specific seroprevalences and bimodal distribution of exposure to L.
intracellularis were unexpected and suggest that farms with a previous history of EPE
remain at risk due to heightened exposure levels beyond early winter, as has been
suggested previously.
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CHAPTER THREE:
Determining the role of passively-acquired antibodies in infection and immunity to
Lawsonia intracellularis

Summary

Much like the other proliferative enteropathies caused by Lawsonia
intracellularis¸ equine proliferative enteropathy typically affects weanlings and is rarely
seen in older horses. Multiple hypotheses to explain age-based susceptibility to develop
L. intracellularis include the decline of passively-acquired antibodies; this has never been
examined in horses. A total of 369 mare and foal pairs from 15 central Kentucky
Thoroughbred farms were ultimately used in this study. Serum samples were collected
from mares and foals within 48 hours of parturition, and then monthly from foals through
February of their yearling year. L. intracellularis-specific antibody levels were
determined using an ELISA previously validated for use in horses. No effect of passively
acquired antibodies on the occurrence of presumptive EPE or suspected infection with L.
intracellularis was noted. In total, 5.3% and 6.3% of seropositive horses developed
presumptive EPE or suspected infection with the bacterium, respectively. Using multiple
logistic regression, it was found that colts were at a significantly greater risk than fillies
of developing presumptive EPE or a combination of presumptive EPE or suspected
infection with the bacterium. Additionally, those horses that were weaned in September
or later months were at a significantly lower risk of developing a combination of either
presumptive EPE or suspected infection. A geographical difference in the timing of
exposure to the bacterium was identified, although no reason for this difference was
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elucidated. This is the first study to show that passively-acquired antibodies to L.
intracellularis do not have an effect on the occurrence of EPE or infection with the
bacterium. A number of novel findings, including identification of the disease rate
amongst exposed horses, warrant additional work as they may help to identify potential
risk factors for L. intracellularis exposure and/or the reservoir host(s) of the bacterium.
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Introduction

Lawsonia intracellularis is an obligate, intracellular, gram-negative curved rod
that invades intestinal crypt cells, primarily in the distal small intestine, and causes
proliferation of the intestinal epithelium.4 This proliferation leads to thickening of the
intestinal mucosa and the clinical signs associated with proliferative enteropathy.14
While initially described as a pathogen of pigs,4 L. intracellularis is now viewed as an
emerging cause of proliferative enteropathy in a variety of mammalian species,91,92
including horses.14,93-95 In the horse, L. intracellularis infection results in equine
proliferative enteropathy (EPE) which has been reported worldwide.15,25 Affected horses
suffer weight loss and some ultimately succumb to the disease despite aggressive
treatment.19
Equine proliferative enteropathy typically affects weanlings and is rarely seen in
older horses.30,31 Diagnosis and preventative measures for EPE are poorly defined while
clinical signs in infected horses are non-specific and include anorexia, fever, lethargy,
depression, and dependent edema, with colic and diarrhea infrequently seen.18
Ultrasonographic thickening of the small intestinal wall (>3mm) in weanlings, although
not reliably seen, is highly suggestive of EPE.14 Antemortem diagnosis of EPE revolves
around clinical signs, ultrasonographic findings, and evidence of hypoproteinemia and
hypoalbuminemia, as well as results from commercially available diagnostic tests.11 The
presence of hypoalbuminemia may be one of the best, most rapid, and inexpensive tests
for EPE in weanlings with other compatible clinical signs.11 Commercially available
antemortem tests include fecal polymerase chain reaction and serum serology using the

59

immunoperoxidase monolayer assay (IPMA). While definitive diagnosis of EPE can
only be made at necropsy and relies upon the immunohistochemical (IHC) detection of
the organism in characteristic intestinal lesions,31 IPMA has been widely used as an
antemortem diagnostic tool for cases of EPE.11,19 The IPMA utilizes a commercially
available antigen coated plate and a HRP-detection method which requires only an
inverted microscope for analysis; however, this method is highly subjective and
dependent on operator experience.106 Enzyme-linked immunosorbent assays (ELISA) are
a more reliable and sensitive test that are readily automated and free of operator
interpretation. ELISAs are frequently used for the detection of antibodies to specific
pathogens and we have recently validated an L. intracellularis-specific ELISA for use in
horses.20
Multiple hypotheses for the predilection of L. intracellularis for weanlings exist,
including the stress of weaning and the decline of maternal antibodies.11,18 While the
nature of the immune response to L. intracellularis remains ill defined, IgG antibodies
have been implicated in protection against both porcine and equine PE.50,88 Past work
has shown that passively acquired antibodies specific to L. intracellularis were detectable
by the IPMA method for 1-3 months post-parturition.107 Given the aforementioned
limitations of the IPMA method, this approach may fail to completely define the true
duration and quantity of the passively acquired antibodies. Our previous work has shown
the incidence of L. intracellularis-seropositive weanlings in the central Kentucky region
approaches 68%, with some farms experiencing 100% weanling seroconversion.20 This
high incidence provides the opportunity to follow groups of foals with varying levels of
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passively-acquired antibodies against L. intracellularis in order to determine the role
these antibodies play in protection from infection and EPE.
Very little is known regarding control of L. intracellularis exposure or other
preventative measures for EPE as risk factors for this disease remain unknown. While
there is interest in the use of a vaccine to prevent this disease,88 no product is currently
licensed for use in horses nor are the protective immunological mechanisms against EPE
defined. If passively-acquired antibodies are protective against the development of EPE,
new preventative measures such as maternal vaccination or administration of L.
intracellularis hyperimmune plasma to foals may be warranted as a means of decreasing
the incidence of clinical disease. Here, we have examined the role that passivelyacquired antibodies to L. intracellularis play in immunity and infection using a large
scale, prospective field study.
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Materials and Methods

Study Farms and Horses
Fifteen Thoroughbred farms in central Kentucky were enrolled in this study
which took place from January 2012 through February 2013. The only requirements for
inclusion were that the farm population of horses be 75% or greater Thoroughbreds and
that the farm be located within a 25 mile radius of Lexington, Kentucky. Preference for
inclusion was given to those farms with a documented history of EPE. Approval to
conduct this study was obtained from the University of Kentucky's Institutional Animal
Care and Use Committee and forms documenting informed consent for inclusion of
privately-owned horses was obtained from the farm managers or farm veterinarians,
whom were authorized to act on the behalf of private owners.
Immediately prior to the study's initiation, one farm elected to withdraw its
participation (Farm 10) while Farm 16 was added as a portion of the foals originally
located on Farm 4 were relocated to Farm 16. Farms 13 and 14 were ultimately regarded
as the same farm as they were part of a complex of farms and, after weaning, study
horses were comingled together.

Sample Collection, Processing, and Storage
Within 48hrs of parturition, whole blood samples (7 mls of peripheral blood
collected via aseptic venipuncture from the jugular vein) were collected from the mare
and newborn foal and allowed to settle in a refrigerator at 4oC. Samples were
individually labeled with regard to the mare/foal’s name, as well as the date the sample
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was collected. If foals received hyperimmune plasma (i.e. Rhodococcus equi) or high IgG
plasma for failure of passive transfer, the farms were requested to obtain the blood
sample after plasma had been administered in an effort to accurately represent L.
intracellularis-specific antibodies obtained from both colostrum and the hyperimmune
plasma. Treatment with these products was noted for later analysis.
After the initial collection time point, samples were subsequently collected
approximately every four weeks only from the foals starting at 4 weeks of age through
the middle of July, as described above. Samples were stored at 4oC on the farm until
returned to the Maxwell H. Gluck Equine Research Center at the University of Kentucky
for centrifugation (800g x 10min) followed by freezing of serum at -20oC until all
samples collected through July from mare/foal pairs could be run concurrently (see
below).
Starting at the end of July, all study horses (ranging in age from two months to six
months) had blood samples collected during the same three day period every four weeks
to ensure that all horses, irrespective of the farm, were sampled during the same time
period. Samples were submitted by the farms and held at centralized laboratories at 4oC
for less than 24hrs before they were collected and transported to the Gluck Equine
Research Center. Upon arrival, samples were immediately centrifuged at 800xg for 10
min and held at 4oC for no more than 4 days before all samples were analyzed as below.

Detection of L. intracellularis-specific antibodies
Serological status in regards to L. intracellularis was determined using the ELISA
method as previously described (see also Chapter 2),20 except that plates were blocked
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with polyvinyl alcohol 1% (w/v) in distilled water for one hour instead of two hours.
Results from the tested sera were converted to an ELISA unit (EU) utilizing a linear
regression line from a standard curve generated on each plate. A positive cut-off of
55EU or greater was utilized based on previous work.10

Data Obtained from Farms
Farms were asked to provide a range of information about each study horse,
including sex, date of birth, post-foaling IgG result, whether hyperimmune or high IgG
plasma was administered, whether the foal was treated for Rhodococcus equi, weaning
date, and any other pertinent comments.

Total Protein and Albumin Determination
Total protein levels were determined via refractometry for all seropositive
samples. For those samples with total protein levels below 5.3 g/dL, albumin levels were
obtained using an ACE Alera (Alfa-Wassermann, West Caldwell, NJ) at the University of
Kentucky’s Veterinary Diagnostic Laboratory. Albumin levels below 3.2 g/dL were
considered to be low. During each sampling period from September to February (those
periods in which seropositive horses were present), between 12-20 seronegative samples
were randomly chosen as negative controls for total protein levels while a subset of those
samples were used as albumin negative controls, all for comparison to total protein and
albumin results from the other groups (see below). Additionally, forty seropositive
samples with total protein levels at or above 5.3 g/dL were randomly chosen for albumin
determination and comparison between the other groups.
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Classification of Study Horse EPE Status
At the end of the study, horses were placed into one of four categories to describe
their L. intracellularis/EPE status following the typical L. intracellularis "season" of
October to February: presumptive EPE, suspect L. intracellularis-infected, seropositive,
or non-exposed. Based on our previous work,20 presumptive EPE affected horses were
those that experienced concurrent clinical signs compatible with EPE, moderate to severe
hypoproteinemia (<4.5g/dL) and hypoalbuminemia (<2.5g/dL), and a positive L.
intracellularis-specific ELISA result. For the purpose of this study, compatible clinical
signs for EPE were anorexia, fever, lethargy, depression, dependent edema, rapid weight
loss, colic, and diarrhea. Given that definitive diagnosis of EPE can only be made at
necropsy and relies upon the immunohistochemical (IHC) detection of the organism in
characteristic intestinal lesions,31 all clinical diagnoses of EPE were considered
presumptive. Suspect L. intracellularis-infected horses were those with mild
hypoproteinemia (4.5-5.2 g/dL) and hypoalbuminemia (2.5-3.1 g/dL) plus a positive L.
intracellularis-specific ELISA result without concurrent clinical signs compatible with
EPE. L. intracellularis-infected horses can experience a transient decrease in total
protein and albumin levels along with a positive L. intracellularis-specific ELISA result
in the absence of other clinical signs.10,39 However, since there was no demonstration of
the presence of L. intracellularis (either via fecal PCR or necropsy sampling), these cases
are referred to as "suspect L. intracellularis-infected". Seropositive horses were those
with only a positive L. intracellularis-specific ELISA result (excluding passivelyacquired L. intracellularis antibodies) and no other indication of L. intracellularis
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infection. Horses with no detectable L. intracellularis-specific antibodies for the entirety
of the study (excluding passively-acquired antibodies) were classified as seronegative.

Data Analysis
Logistic regression analysis was used to identify significant effects of different
variables on EPE/L. intracellularis status including, but not limited to initial EU value,
use of any hyperimmune plasma, Rhodococcus equi infection, and weaning month. Oneway analysis of variance (ANOVA) was used to detect significant differences between
seropositive groups (presumptive EPE, suspected infected, and seropositive-only) with
respect to age at weaning, age at seroconversion, and time from weaning to
seroconversion, as well as differences in the age at weaning between seronegative and
seropositive horses. One-way ANOVA was also used to detect total protein and albumin
differences between classification groups. Additionally, survival analysis (KaplanMeier) was used to determine the effect of initial serological status of the foal on time to
seroconversion. To determine the effect of passively-acquired antibodies on
seroconversion rates in the study population, analysis was performed using proportional
hazards regression analysis (Cox PH regression) with maternal and initial foal antibody
EU values as variables and seroconversion as the event. Calculated P values <0.05 were
considered to be statistically significant.
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Results

A total of 453 mare and foal pairs were initially enrolled in the study, from which
initial, post-partum samples were collected. From these pairs, 253 mares were
seronegative (<55EU) and 200 (44.2%) were seropositive post-parturition (55-1297 EU)
while 281 foals were seronegative and 172 (38.0%) were seropositive (55-2552.6 EU).
Average positive EU values for mare and foal post-partum samples were 135.5 and 164.7
EU, respectively. Interestingly, 41 foals were seropositive at parturition while samples
from their mares were seronegative; these values ranged from 55.2 EU to 155.7 EU. Of
these 41 foals, 35 had received Rhodococcus equi hyperimmune plasma. A variety of R.
equi hyperimmune plasmas given to study foals were tested for L. intracellularis-specific
antibodies and found to vary greatly; an average EU value of 130 EU was noted, although
samples ranged from negative (<55EU) to a maximum of 919 EU. Passively-acquired
antibodies to L. intracellularis above the 55EU cutoff were not detected in foals beyond
the third collection (2 months of age), although two foals from the same farm (Farm 14)
appeared to seroconvert during April and May (data not shown) as their mare and prior
samples had been negative.
From the initial 453 mare and foal pairs, a total of 369 study horses were present
through at least October 2012 and included in the final statistical analysis. Information
regarding individual farms with respect to the number of study horses present through at
least October, the number of presumptive EPE cases and suspect infected horses, and
farm-specific seroprevalence from August 2012 to February 2013 is included in Table
3.1. Also included in Table 3.1, if available, is the previous year’s seroprevalence for
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Table 3.1: Pertinent information regarding individual farms including the study-period seroprevalence and previous year's
seroprevalence, if available.
Initial # of
Study
Horses
16

# of Study Horses
Present Through At
Least October
7

# of
Presumptive
EPE Cases
0

# of Suspect, L.
intracellularis
Cases
0

Study Period
Seroprevalence
50.0%

Previous
Year's
Seroprevalence
60.0%

26
3
4
5
6
7

128
15
30
9
39
4

92
15
19
8
38
4

44
0
0
0
2
0

2
0
2
0
4
0

55.4%
11.8%
68.0%
70.0%
73.7%
25.0%

56.7%
27.8%
71.9%
20.0%
23.6%
75.0%

8

28

28

1

0

52.9%

28.1%1

9

17

16

2

1

77.8%

72.2%2

11

10

10

1

1

36.4%

57.1%3

12

11

10

0

1

80.0%

33.3%3

13 & 14

109

89

15

0

36.4%

N/A

6

21

18

0

2

72.7%

N/A

166

16

15

0

0

75.0%

N/A
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Farm
Number
1

15
1

Samples collected early October to January 2012

2
3

Samples collected late October to January 2012

Samples collected late November to January 2012

4

One presumptive EPE case occurred in March 2013 and another in April- both were included in the data set

5

The presumptive case of EPE was euthanized and a necropsy could not be performed in a timely manner

6

Farm had at least one case of presumptive EPE in a non-study horse

each farm, which was collected with methods similar to as above from September 2011
to January 2012.
The combined seroprevalence for all study horses was 56.4% (208 seropositive
horses) while farm-specific seroprevalences ranged from 11.8% to 80% (Table 3.1).
Figure 3.1 shows the monthly percentage of previously seronegative horses that
seroconverted during a given month where peak seroconversion rates were noted in
October and January. Additionally, the cumulative percentage of all seropositive study
horses during a given month is also included on Figure 3.1. Seroconversion data from
each of the previous three years (2010-11, 2011-12, and 2012-13), using approximate
dates for comparison, are provided in Figure 3.2. Figure 3.3 shows a representation of
first-time seroconversions from the current study by each farm's geographic region and
Figure 3.4 is provided to demonstrate the respective geographic regions.
During the study, a total of 11 horses developed presumptive EPE (3.0% of all
study horses and 5.3% of seropositive horses) while an additional 13 developed suspected
L. intracellularis infection (3.5% of all study horses and 6.3% of seropositive horses).
Two horses from Farm 2 developed presumptive EPE outside of the scheduled serum
screening period (one in March 2013 and another in April 2013) but were included in the
presumptive EPE data set as they met the criteria for inclusion. Tables 3.2 and 3.3
contain signalment and other pertinent information for the presumptive EPE and suspect
infected horses, respectively.
Total protein and albumin values for the four classification groups were analyzed
using one-way ANOVA with significant differences noted for total protein and albumin
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Figure 3.1: Monthly seroconversion rate and the monthly total percentage of seropositive horses.
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Figure 3.2: Regional seroconversion data from 2010-11,20 2011-12, and 2012-13. Dates are approximate.
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Figure 3.3: 2012-13 seroconversion data based on each farm's geographical location.
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Figure 3.4: Approximations of the geographical categories used in Figure 3.3. The map has been modified from Google Earth.

Table 3.2: Signalment and other pertinent information from study horses with presumptive EPE.

Horse
ID
075
109
111
137
249
253
359
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366
371
596
505

Farm
2
2
2
2
6
6
8
9
9
11
14

DOB
3/10/12
2/25/12
3/29/12
3/24/12
4/9/12
3/1/12
2/8/12
4/12/12
5/3/12
2/3/12
5/27/12

Sex
Colt
Colt
Filly
Colt

IgG
>800
>800
>800
>800

HighIgG
Plasma
No
No
No
No

Colt
Filly
Colt
Colt
Colt
Colt
Colt

Not
Reported
>800
>800
>800
>800
>800
400-800

No
No
No
No
Yes
No
No

R. equi
Plasma
Yes
Yes
Yes
Yes

R. equi
Treatment
No
No
No
No

Weaning
Month
August
July
August
August

Mare
EU
Value
Neg
83
Neg
Neg

Initial
Foal EU
Value
Neg
82.6
Neg
Neg

Yes
Yes
Yes
No
No
No
Yes

No
No
No
No
No
No
No

Sept
July
July
August
August
July
Sept

Neg
Neg
92.2
Neg
Neg
89.4
Neg

Neg
Neg
309
Neg
Neg
59.6
Neg

*No albumin result was reported immediately after clinical signs were noted. The value
reported here was recorded 2 weeks after the onset of clinical signs and not included in data
analysis.

EPE Date
12/29/12
3/18/13
2/8/13
4/3/13

Total
Protein
(g/dL)
3.6
3
3.8
3

Albumin
(g/dL)
2.5*
1.6
2.1
1.2

10/16/12
10/15/12
12/31/12
10/8/12
10/21/12
10/15/12
1/27/12

3.2
2.6
2.5
3.7
3.8
3.6
2.6

2.3
1.4
1.1
2.2
2
1.7
1.2

Table 3.3: Signalment and other pertinent information from study horses with suspected L. intracellularis infection.

Horse
ID
060
101
225
230
255
265
276

75

282
375
399

Farm
2
2
4
4
6
6
6
6
9
11

420
588
589

12
15
15

DOB
4/17/12
1/16/12
2/13/12
2/14/12
3/11/12
2/28/12
2/8/12
4/10/12
2/8/12
3/9/12

Sex
Colt
Colt
Filly
Colt
Filly
Filly
Colt
Colt
Colt
Filly

IgG
>800
>800
400-800
>800
>800
>800
>800
>800
>800
>800

Not
3/29/12 Colt Reported
2/6/12 Colt
>800
2/14/12 Colt 400-800

HighIgG
R. equi
Plasma Plasma
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
Yes
No
No
No
No
No
No
No

No
Yes
Yes

Initial
Mare Foal
EU
EU
R. equi
Weaning
Date of
Treatment Month Value Value Diagnosis
No
October 95.3
Neg
1/14/13
No
June
96.2
146
2/11/13
Yes
August
58.5
Neg 12/19/12
No
June
59.8
67.7 12/19/12
No
August
Neg
Neg
9/25/12
No
July
Neg
Neg 10/23/12
No
June
Neg
Neg 10/23/12
Yes
August
61.7
159 12/19/12
Yes
May
Neg
Neg 10/23/12
No
August
Neg
Neg 10/23/12
No
No
No

August
July
July

Neg
106
Neg

Neg
123
Neg

10/23/12
10/23/12
10/23/12

Total
Protein
(g/dL)
4.6
5
5
5.2
4.6
5
5.2
5.2
5.1
5

Albumin
(g/dL)
2.8
2.9
3
3.1
2.8
2.9
2.9
2.9
2.7
3.1

4.8
4.8
5

2.3
2.8
3.1

between all of the groups except seronegative and seropositive (Figures 3.5 and 3.6).
Table 3.4 provides values for each group, including minimum and maximum values
observed, as well as the 95% confidence interval for each group. While there was an
overlap in the confidence intervals between suspect infected and seronegative horses,
there were no seronegative horses that had values for both total protein and albumin
outside the calculated confidence interval, nor were there any outside the reference range
used for group classification (TP <5.3 g/dL and albumin <3.2 g/dL).
One-way ANOVA was used to examine the different seropositive groups
(presumptive EPE, suspect infected, and seropositive-only) for differences in ages at
weaning and seroconversion, as well as the amount of time elapsed between weaning to
seroconversion. Table 3.5 has values for each group, as well as an average of the three
groups with respect to time from weaning to seroconversion and age at seroconversion.
No significant differences were noted between the three groups; however, there was a
significant difference (p<0.001) between the mean age at weaning between seronegative
and all seropositive horses (152 days vs. 144 days, respectively). The earliest detectable
exposure to L. intracellularis occurred 8 days prior to weaning and the latest at 258 days
after weaning while the overall average of time from weaning to seroconversion between
the three groups was 125 days. The youngest horse to seroconvert during the fall and
winter months was 150 days old and the oldest 392 days old while the average age at
seroconversion was 178 days (approximately 6.5 months).
The effect of passively-acquired antibodies on time to seroconversion in study
horses was examined using a Kaplan-Meier curve (Figure 3.7) and no differences were
noted between those foals that were seropositive versus seronegative immediately after
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Figure 3.5: Total protein data from study horses based on their categorization.
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Figure 3.6: Albumin data from study horses based on their categorization.
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Table 3.4: Minimum, maximum, and calculated 95% confidence intervals for total
protein and albumin based on study horse categorization. Units are g/dL.
TOTAL PROTEIN
Classification
Presumptive EPE
Suspect LI Infection
Seronegative
Seropositive
ALBUMIN
Classification
Presumptive EPE
Suspect LI Infection
Seronegative
Seropositive

Reported
Minimum
2.5
4.6
5.2
5.2

Maximum
4
5.2
7
6.9

Reported
Minimum
1.1
2.3
3.1
2.9

Maximum
2.3
3.1
3.8
3.8
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Calculated
Low
High
95% CI
95% CI
2.1
4.3
4.6
5.4
5.1
6.3
5.2
6.4
Calculated
Low
High
95% CI
95% CI
0.8
2.5
2.4
3.3
3.1
3.8
3.0
3.8

Table 3.5: Ages (in days) for the various horse classification categories.

Average Age at Weaning
Median Age at Weaning
Standard Deviation Age at Weaning
Minimum Age at Weaning
Maximum Age at Weaning
Average Time from Weaning to Seroconversion
Median Time from Weaning to Seroconversion

Suspect, L.
Presumptive intracellularis Seropositive
EPE
infection
Only1
144
145
144
149
147
144
19
23
21
103
83
59
164
177
213

Average of
All
Seropositive
Horses
144
145
21
59
213

Seronegative
Horses
152
152
22
109
213
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Standard Deviation Time from Weaning to Seroconversion
Minimum Time from Weaning to Seroconversion
Maximum Time from Weaning to Seroconversion

134
144
67
32
234

118
102
52
54
240

122
118
49
-8
258

125
122
57
-8
258

N/A
N/A
N/A
N/A
N/A

Average Age at Seroconversion
Median Age at Seroconversion
Standard Deviation Age at Seroconversion
Minimum Age at Seroconversion
Maximum Age at Seroconversion

277
262
75
172
387

263
257
50
197
392

269
267
52
150
392

266
263
56
150
392

N/A
N/A
N/A
N/A
N/A

1

Does not include two foals from Farm 14 that may have been exposed during April and May

Seronegative Proportion
Figure 3.7: Survival analysis of seroconversion time-point based on the foal's postpartum antibody status. Time-points are 1= July, 2=August, 3=September,
4=October, 5=November, 6=December, 7=January, and 8=February.
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birth. Further, Cox proportional hazards analysis revealed no significant effect of either
post-partum maternal or foal antibody status on the timing of seroconversion (data not
shown).
Multiple logistic regression analysis of data obtained for each study horse was
performed using the occurrence of presumptive EPE, suspected L. intracellularis
infection, and a combination of presumptive EPE or suspected L. intracellularis infection
as the dependent variables. P-value results and odds ratios calculated from the analysis
are included in Table 3.6. Of the parameters analyzed, colts were at a significantly
greater risk for the development of presumptive EPE (p=0.038, odds ratio 5.299) or a
combination of presumptive EPE or suspected infection (p=0.006, odds ratio 3.861).
There was a trend (p=0.086, odds ratio 2.955) for colts to be at greater risk of developing
suspect L. intracellularis infection. Additionally, those horses that were weaned in
September or later months were at a significantly lower risk of developing a combination
of either presumptive EPE or suspected infection (p=0.047, odds ratio 0.281). Thirtyeight study foals were treated for suspected Rhodococcus equi infection during the study,
and while the use of hyperimmune R. equi plasma did not affect the occurrence of EPE,
there was a trend for R. equi treatment to have a positive effect on the occurrence of
suspected L. intracellularis infection (p=0.076, odds ratio 3.69).
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Table 3.6: Odds ratios calculated from multiple logistic regression analysis. The parameter in () was analyzed as the positive
response.
Dependent Variable

LOGISTIC REGRESSION ODDS RATIO
Sex (Colt)
R. equi Plasma (Yes)
High IgG Plasma (Yes)
R. equi Treatment (Yes)
Weaning Month (Sep-Nov vs. May-Aug)
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Mare EU value at Parturition (Positive)
Foal EU value at Parturition (Positive)
* p<0.1, **p<0.05, ***p<0.01

Presumptive EPE
5.299**
0.466
2.298
0
0.444
0.608
0.666

Suspect, L.
intracellularis
infection
2.955*
0.804
0
3.69*
0.168*
2.067
0.402

Both Presumptive
EPE & Suspected L.
intracellularis
Infection
3.861***
0.602
0.89
1.393
0.281**
1.159
0.507

Discussion

Recognition of a necrotizing form of equine proliferative enteropathy,9 as well as
previous work suggesting a significant economic impact of EPE,11 emphasizes the
importance of understanding the principles of infection and immunity to L. intracellularis
in horses. Despite the decline of passively-acquired antibodies (especially maternally
derived antibodies) as a possible explanation for the susceptibility of weanlings to L.
intracellularis infection, very little work in any species has examined this possibility.
Here, relying on a large field study with naturally occurring cases, we have examined the
effect of passively-acquired antibodies and found that they do not have a significant
effect on the occurrence of EPE or suspected L. intracellularis infection. Further, we
have identified and documented an accurate disease attack rate for EPE and shown that
weanling/yearling age does not appear to be a risk factor for the occurrence of clinical
EPE or L. intracellularis infection.
While only three of the eleven (27.3%) presumptive EPE cases and four of the
thirteen (30.8%) suspected L. intracellularis infections had detectable, passively-acquired
L. intracellularis-specific antibodies following birth, these proportions were similar to the
total percentage of seropositive foals following birth (38%). The overall percentage of
mares that were seropositive at parturition (44.2%) was lower than had been expected,
especially given that L. intracellularis appears to have become a relatively ubiquitous
organism on many farms in central Kentucky and previous work by others has found
seropositive rates in adult horses from 55-90+%.19,20,107,108 One potential confounding
factor in this study was the prevalent use of Rhodococcus equi hyperimmune plasma on
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many of the farms. We believe that this plasma, which contained variable levels of L.
intracellularis-specific antibodies, may have affected the initial post-partum foal
antibody levels. In fact, 35 of the 41 foals with seropositive post-partum samples while
their mare's corresponding sample was seronegative received R. equi hyperimmune
plasma. Of the six remaining foals with positive values, their mare's L. intracellularis
antibody levels likely fell slightly below the cutoff (55EU) and, thus, were reported as
negative. While data analysis failed to demonstrate an effect of the R. equi plasma on the
occurrence of EPE, we opted to refer to the L. intracellularis-specific antibodies that
were measured post-partum as passively acquired to account for those that were
potentially obtained through hyperimmune plasma administration, rather than just from
colostrum intake.
Gender was found to have a significant effect on the occurrence of EPE, with
colts being significantly more likely to develop presumptive EPE or a combination of
presumptive EPE or suspected infection. Out of the 369 study horses present in that data
analysis, 164 were colts, 177 were fillies, and 28 were not reported. It is important to
note that while data analysis indicated an increased risk for colts, fillies also developed
both presumptive EPE and suspected L. intracellularis infections during the study and
there have been numerous case reports of EPE in fillies as well.9,11,31,109 There was a
trend (p=0.076) for those horses that were treated as foals for R. equi to be at greater risk
(odds ratio 3.69) of developing suspect infections than those horses not treated for R.
equi. Likewise, there were no presumptive EPE cases that were treated for R. equi as
foals. While a larger sample set is needed to examine this further, it is possible that prior
infection with R. equi may have some protective effects against L. intracellularis
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infection given that they are both intracellular bacteria and likely require a competent
interferon-gamma response by the immune system to clear the infection (see Chapter 5
below).10,110,111 Prior R. equi infection may prime the foal's immature immune system
such that, when challenged with L. intracellularis, the immune system is capable of
recognizing the intracellular bacterium and responding appropriately. Further study into
the possibility of cross-protection, using either naturally occurring field cases or
experimentally challenged horses, is warranted.
Interestingly, when looking for an effect of weaning date on EPE occurrence,
those horses weaned between September and November were at a significantly lower risk
of developing combined presumptive EPE and suspected L. intracellularis infection
when compared to those horses weaned between May and August. The reason for this
difference is not immediately clear and testing over additional years is needed to identify
whether this is a recurring predilection or a one-time occurrence. One possible
explanation could be that mares provide an unknown protective effect for their foals. By
not being weaned until during or after an exposure period (such as what was seen in this
study during October), the late-weaned foals may be shielded from exposure.
While clinical EPE is exceedingly rare in nursing foals, it appears as though several study
horses were exposed to the bacterium prior to weaning since it takes approximately 14
days for seroconversion to occur following exposure;10,39 in addition to the two foals that
seroconverted during April and May while still on their mares, one seropositive horse
seroconverted 8 days prior to weaning while two other horses seroconverted 9 and 10
days after weaning (data not shown). With prior work suggesting that horse-to-horse
transmission of L. intracellularis is possible,39 as well as the suggestion that sows may
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serve as a reservoir for the bacterium, 59 mares may play a role in the epidemiology of
EPE, a possibility that is explored in Chapter 4.
Given that there were no significant differences in age at weaning and
seroconversion or in the time from weaning to seroconversion between the three
seropositive groups, it would appear that age does not play a factor in the development of
EPE or L. intracellularis infection when exposed to the bacterium. While it was found
that seronegative horses were significantly older (by 8 days) at weaning than seropositive
horses, there is no readily apparent explanation for this finding other than what has been
mentioned above. It seems unlikely that an additional 8 days with its mare would provide
complete protection from detectable L. intracellularis exposure in the months following
weaning, however, a large, risk-factor based study would be needed to examine this
beyond the scope of what has been presented here.
We previously reported a regional seroprevalence of 68%,20 while in the study
reported here the overall seroprevalence was 56.4%. Given the preference to include
those farms with prior EPE, neither of these rates are indicative of the overall
seroprevalence rate in central Kentucky; instead, farm-specific seroprevalence levels
allow for a better examination of L. intracellularis exposure. To that end, the farmspecific seroprevalences reported here, which ranged from 11.8-80%, were similar to
those we have reported earlier where values ranged from 14-100%.20 Interestingly, the
bimodal distribution of exposure noted in the previous study (2010-11) was again noted
here (2012-13), with peak exposures in October and January, while only a single peak of
exposure for the entire central Kentucky region was seen in 2011-12. Upon examining
the location of the current study's farms, it is evident that there is only a single peak of
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exposure for each region in a given season. Potential reasons for the regional differences
include management practices, vaccination schedules, reservoir and/or wildlife
population changes/fluctuations, and weather patterns. For those farms with
seroprevalence data available from the prior year, the change in seroprevalence was
varied, with some farms experiencing large increases or decreases, while others remained
static; no immediate reasons for these changes were evident, however, this study was not
designed to examine for differences between farms. In-depth examination of the
potential reasons behind the regional and year-to-year farm exposure differences might
help to identify potential risk factors for L. intracellularis exposure and/or the reservoir
host(s) of the bacterium.
The fall and winter months (October through February) continue to be the primary
time during which exposure to L. intracellularis is detected and when the majority of
EPE cases occur in central Kentucky. However, the occurrence of EPE cases beyond
February,20 including the March and April 2013 cases reported here, suggest that this
range should be extended. Further, the apparent seroconversion of two nursing foals in
April and May of 2012, while only a fraction of the entire study population, would also
seem to support this assertion.
Hypoproteinemia with hypoalbuminemia has long been recognized as a common
occurrence with EPE and is unique amongst the species L. intracellularis infects. This
upset in total protein and albumin levels is what leads to dependent edema, one of the
non-specific but common findings with EPE cases. Prior to data analysis and based on
our clinical experience, we set the ranges listed above (TP: <4.5g/dL and 4.5-5.2 g/dL,
albumin: <2.5g/dL and 2.5-3.1 g/dL) for presumptive EPE cases and suspect L.
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intracellularis-infected horses, respectively. Not surprisingly, total protein and albumin
were significantly different between the various groups, except for those differences
between seronegative and seropositive-only horses. Further, the values that we set prior
to analysis held up fairly well when compared to the calculated 95% confidence interval
values. Although variations in sample analysis will exist between methods and
laboratories, the references ranges we have provided for presumptive EPE (TP <4.5 g/dL
and albumin <2.5 g/dL) and suspected infection (TP 4.5-5.2 g/dL and albumin 2.5-3.1
g/dL) cases appear to provide a good starting point for the classification of EPE cases.
While there were several seronegative and seropositive horses with either total protein or
albumin values below the reference ranges used here, none of them had concurrent
hypoproteinemia and hypoalbuminemia, stressing the importance of evaluating both
parameters in tandem. There can be several other causes of low total protein and albumin
in young horses, and given that total protein and/or albumin have been targeted as a
cheap and effective means of screening for EPE (including weekly screening of total
protein by one farm in this study), it remains important to follow-up abnormal values
with serologic screening prior to initiating treatment for L. intracellularis infection.
A point of discussion for several years has been how infrequently clinical disease
occurs in weanling and yearling horses exposed to L. intracellularis. While this study
sought to examine some of the potential risk factors for EPE, another goal was to
determine the disease and infection rate among exposed horses. Traditionally, estimates
of 5-10% of clinical EPE in seropositive horses have been used, but this assumption has
never been proven in a large scale, field study before. Much like the overall
seroprevalence we reported above, the attack rates amongst the entire study population
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should be used with caution as the preferential inclusion of EPE endemic farms likely
introduced a sampling bias. Among L. intracellularis-exposed horses, we found a
clinical EPE attack rate (using the presumptive EPE cases) of 5.3% and an infection
attack rate (using cases with suspected infections) of 6.3%; combined, there was an
overall attack rate of 11.6% among seropositive horses. Current experimental L.
intracellularis challenge models in horses induce clinical EPE at a rate of 33% or
higher,10,39,57 suggesting that these models fail to mimic natural exposure to the bacterium
and likely over-expose horses to elicit disease. With this newly documented attack rate,
it should be possible to refine the experimental challenge models used to induce EPE,
likely by decreasing the challenge doses, such that they more closely mimic natural
disease.
By showing that passively-acquired antibodies specific for L. intracellularis failed
to have a significant, protective effect against the occurrence of EPE, we have eliminated
a potential explanation for the unique predisposition of young horses to EPE. Given that
passively-acquired IgG is short-lived, IgG is the predominant immunoglobulin in
colostrum and hyperimmune plasma products, and L. intracellularis infection is not a
systemic infection but rather a localized, mucosal infection, it is not surprising that no
significant effect of passively-acquired antibodies was noted in this study. Other
potential reasons for weanling predisposition to EPE continue to include management
changes associated with weaning and the post-weaning period (including stress), loss of
maternally-derived nutrition and immunological factors (i.e. IgA), and the immune
response to intracellular infection. Based on the findings presented here, age does not
appear to have an effect on EPE occurrence amongst seropositive horses while age at
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weaning might have an effect on seroconversion. Colts were found to be significantly
more at risk for the development of EPE and L. intracellularis infection, however, fillies
do account for many clinical cases of EPE. The identification of geographical exposure
differences within a relatively small area is a novel finding that warrants further
exploration as the reason(s) behind this difference may provide the first clues towards
understanding the epidemiology of L. intracellularis infections on horse farms. Even
though the disease rate demonstrated here (approximately 11% of seropositive horses) is
relatively low compared to other equine diseases, the growing economic and welfare
aspects of EPE suggest that it is a disease which should not be ignored.

Copyright © Allen Edward Page 2013
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CHAPTER FOUR:
Determining whether mares play a role in the epidemiology of Lawsonia
intracellularis and equine proliferative enteropathy on an endemic farm

Summary

The epidemiology of equine proliferative enteropathy is poorly characterized,
although it is known that a large number of animal species are capable of shedding
Lawsonia intracellularis in feces. Recently it has been suggested that horse-to-horse
transmission of the bacterium may be possible, although no work has examined the role
mares may play in the epidemiology of EPE. The goal of this study was to utilize
serological screening to detect exposure to L. intracellularis. Serum samples were used
to determine whether mares show signs of exposure to the bacterium prior to their foals
and whether seropositive mares were more or less likely to have seropositive
foals/weanlings. Ultimately, 95 mares and 91 foals from a central Kentucky
Thoroughbred farm with endemic EPE were utilized for this study and all foals were
weaned by the end of October. Serum samples were analyzed using an equine-validated
ELISA for L. intracellularis. Chi-square analysis found that those mares with 5 or more
seropositive months through October had a significantly higher number of
foals/weanlings with evidence of exposure to the bacterium and these foals were 5.667
times more likely to be seropositive from July 2012 through January 2013 of their
yearling year than those foals from mares with fewer than 5 seropositive months through
October. There was no effect of mare sero-status on the occurrence of presumptive EPE
or suspected L. intracellularis infection in their offspring. While this study found that
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previously seronegative mares and weanlings experienced similar seroconversion events
in December and January, a role for mares in the epidemiology of EPE or spread of L.
intracellularis could not be ruled out based on the results of this study.
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Introduction

Lawsonia intracellularis is the causative agent of equine proliferative enteropathy
(EPE),14 a disease typically seen in weanlings and young yearling horses during the fall
and early winter months.11 The most common clinical signs observed with EPE include
anorexia, fever, depression, dependent edema, colic, and diarrhea. Diagnosis revolves
around the presence of clinical signs, clinicopathologic disturbances including
hypoproteinemia and hypoalbuminemia, and thickened small intestinal segments detected
via abdominal ultrasound. Additional antemortem tests for the detection of L.
intracellularis infection include analysis for presence of the pathogen shed in feces by
use of an L. intracellularis–specific PCR assay and analysis of serum samples for
bacterium-specific antibody detection.
With respect to the epidemiology of L. intracellularis, a fecal-oral route of
infection is suspected, and what little else is known has been primarily discovered
through research with porcine PE and extrapolated into other species. In addition to
horses, pigs, and hamsters, several studies have revealed the presence of L. intracellularis
a variety of species, including blacktailed jackrabbits, cottontailed rabbits, cats, striped
skunks, Virginia opossums, coyotes, guinea pigs, mice, rats, hamsters, hedgehogs, ferrets,
rabbits, wild pigs, dogs, foxes, calves, wolves, deer, ostriches, emus, monkeys, and
giraffes.1,45-47 Thus far, attempts to incriminate any of these species in the spread or
maintenance of L. intracellularis within susceptible populations have only been
suggestive and not proven conclusively; this includes a recent study in which weanling
horses were challenged with feces from L. intracellularis-infected rabbits.44 In that
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study, the challenged horses failed to develop EPE, however they did seroconvert
following challenge. Work with porcine PE has, however, implicated subclinically
affected pigs in the spread of the bacterium in swine operations 52 and recent work with
EPE has suggested a role for clinically affected horses.39 Further, some have suggested
the potential for sows to harbor and transmit the bacterium to their offspring,59 an aspect
of which has never been examined with EPE. Given that most Thoroughbred foals are
co-housed in stalls with their respective mares for multiple hours per day, as well as the
propensity for foals to exhibit coprophagic tendencies, it seems tenable that mares could
act as asymptomatic shedders of the bacterium and expose their foals to L. intracellularis
prior to weaning.
The goal of this study was to utilize monthly serum sampling of mares and foals
on an EPE endemic farm to detect exposure to L. intracellularis and determine whether
mares show signs of exposure to the bacterium prior to their foals. Additionally, we
sought to determine whether seropositive mares were more or less likely to have
seropositive foals/weanlings. Should we show that mares may play a role in the exposure
of foals/weanlings to L. intracellularis, this finding would warrant further exploration
with regards to the epidemiology of EPE, as well as examination of potential steps for
mitigation of this exposure as a means of decreasing equine proliferative enteropathy.
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Materials and Methods

Study Farms and Horses
A Thoroughbred farm in central Kentucky, located within 20 miles of the
University of Kentucky, was enrolled in this study, which took place from January 2012
through January 2013. The farm was considered endemic for EPE as it experienced
multiple (3+) cases of clinical EPE in each of at least the three prior years. Approval to
conduct this study was obtained from the University of Kentucky's Institutional Animal
Care and Use Committee and forms documenting informed consent for inclusion of
privately-owned horses were obtained from the farm veterinarian, who was authorized to
act on behalf of private owners.

Sample Collection, Processing, and Storage
Within 48hrs of parturition, whole blood samples (7 mls of peripheral blood
collected via aseptic venipuncture from the jugular vein) were collected from the mare
and newborn foal and allowed to settle in a refrigerator at 4oC. Samples were labeled
with the mare/foal’s name and the date of collection. After collection, samples were
stored at 4oC on the farm until returned to the Maxwell H. Gluck Equine Research Center
at the University of Kentucky for centrifugation (800g x 10min) followed by freezing of
serum at -20oC.
After the initial collection time point, samples were subsequently collected
approximately every four weeks from each mare and foal through the middle of July, as
described above. Starting at the end of July, all study horses (mares and foals) had blood
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samples collected during the same three day period every four weeks to ensure that all
horses were sampled during the same time period. These samples were transported to the
Gluck Equine Research Center and immediately centrifuged at 800xg for 10 min.
Foal/weanling samples were held at 4oC for no more than 4 days before all samples were
analyzed each month, as below, while mare samples were frozen at -20oC. After the final
collection of blood samples in January, samples from each mare were thawed and run
concurrently on the same plate using an L. intracellularis-specific ELISA (see below).

Detection of L. intracellularis-specific antibodies
Serological status in regards to L. intracellularis was determined using the ELISA
method as previously described (see also Chapter 2),20 except that plates were blocked
with polyvinyl alcohol 1% (w/v) in distilled water for one hour instead of two hours.
Results from the tested sera were converted to an ELISA unit (EU) utilizing a linear
regression line from the standard curve generated from each plate. A positive cut-off of
55EU or greater was utilized based on previous work.10

Classification of Study Horse EPE Status
At the end of the study, horses were placed into four categories to describe their
L. intracellularis/EPE status following the typical L. intracellularis "season" of October
to February: presumptive EPE, suspect L. intracellularis-infected, seropositive, or nonexposed. Based on our previous work,20 presumptive EPE affected horses were those
that experienced concurrent clinical signs compatible with EPE, moderate to severe
hypoproteinemia (<4.5g/dL) and hypoalbuminemia (<2.5g/dL), and a positive L.
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intracellularis-specific ELISA result. For the purpose of this study, compatible clinical
signs for EPE were anorexia, fever, lethargy, depression, dependent edema, rapid weight
loss, colic, and diarrhea. Given that definitive diagnosis of EPE can only be made at
necropsy and relies upon the immunohistochemical (IHC) detection of the organism in
characteristic intestinal lesions,31 all clinical diagnoses of EPE were considered
presumptive. Suspect L. intracellularis-infected horses were those with mild
hypoproteinemia (4.5-5.2 g/dL) and hypoalbuminemia (2.5-3.1 g/dL) plus a positive L.
intracellularis-specific ELISA result without concurrent clinical signs compatible with
EPE. L. intracellularis-infected horses can experience a transient decrease in total
protein and albumin levels along with a positive L. intracellularis-specific ELISA result
in the absence of other clinical signs.10,39 However, since there was no demonstration of
the presence of L. intracellularis (either via fecal PCR or necropsy sampling), these cases
are referred to as "suspect L. intracellularis-infected". Seropositive horses were those
with only a positive L. intracellularis-specific ELISA result (excluding passivelyacquired L. intracellularis antibodies) and no other indication of L. intracellularis
infection. Horses with no detectable L. intracellularis-specific antibodies for the entirety
of the study (excluding passively-acquired antibodies) were classified as seronegative.

Data Analysis
Fisher's exact test was used to determine whether mare serological status had an
effect on the occurrence of EPE while Chi-square and risk factor analysis were used to
determine whether the number of seropositive months a mare experienced had a
significant effect on seroconversion in her foal. Additionally, survival analysis (Kaplan-
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Meier) was used to detect an effect of mare serological status on foal seroconversion.
Calculated P values <0.05 were considered to be statistically significant.
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Results

Initially, 130 mare and foal pairs were enrolled in this study, however only 95
mares and 91 foals were ultimately included in the final data analysis as they were
present on the farm from parturition through at least October. Of the 95 mares, 42
(44.2%) were seropositive (≥55EU) at parturition, which ranged from January through
May, while a total of 67 mares (70.5%) were seropositive at some point during the study.
There was an overall decline in the percentage of mares that were seropositive for L.
intracellularis-specific antibodies over the course of the study from January 2012 to
January 2013 (Figure 4.1). The total number of positive samples varied, with 29.5% of
mares remaining seronegative across all of their samples while a total of 46.3% of mares
were seropositive for six or more months during the study (Table 4.1). The average mare
seropositive ELISA value was 108.1EU while the maximum during the study was
1106.3EU.
To allow for easy comparison of antibody levels between mares, mare EU values
were standardized to a fold-change scale by dividing each month's value by the first
result that was reported for that mare; if the first recorded result was negative, a
numerical value of 54.9 EU was assigned while all negative values were disregarded
when averaging positive EU fold changes. Figure 4.2 demonstrates the monthly average
fold changes that were noted amongst the mare samples (a fold change of 1 is equal to no
change). Also included on Figure 4.2 are the first-time seroconversions for mares and
weanlings which were used as an indicator of exposure to the bacterium. Mares had to
have been
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Figure 4.1: Total percentage of study mares that were seropositive during a given month and the average monthly positive EU
value.

Table 4.1: The number and percentage of study mares that were either seronegative for the entirety of the study or
seropositive for a range of months.

Number of Mares
Total Percentage

Negative
28
29.5%

Positive for <3
months
17
17.9%

Positive for 3-5 months
6
6.3%

Positive for 6-9 months
31
32.6%

Positive for 10+
months
13
13.7%
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Figure 4.2: Mare EU fold changes by month, as well as mare and foal seroconversion percentages.

seronegative since the beginning of the study and for the two following samplings for a
subsequent positive sample to be considered seroconversion resulting from exposure to L.
intracellularis. Peak fold changes amongst previously seropositive mares were noted in
June to August, November, and January while small peaks in mare seroconversion were
noted in July and October, with a large peak in mare seroconversion seen in January.
Small increases in foal/weanling seroconversion occurred in June and July (0.8% of foal
population) and November (1%) while large increases in seroconversion occurred in
December and January. All study foals were weaned by the November sample
collection.
Chi-square analysis determined that those mares with 5 or more seropositive
months through October had a significantly higher number of foals/weanlings with
evidence of exposure to the bacterium between July and January (p<0.001). Further,
foals/weanlings from mares with 5 or more seropositive months through October were
found to be 5.667 times more likely to be seropositive from July through January than
those from mares with fewer than 5 seropositive months through October. No significant
effect of mares with 5 or more seropositive months through October was noted on the
occurrence of presumptive EPE or suspected L. intracellularis infection. Based on
survival analysis, no significant difference in the time to seroconversion was noted
between foals/weanlings from mares that were seropositive versus seronegative from
parturition through October (Figure 4.3).
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Seronegative Proportion
Figure 4.3: Survival analysis of the time to foal seroconversion based on whether the
foal's mare was seropositive or seronegative through October. Time-points are 1=
July, 2=August, 3=September, 4=October, 5=November, 6=December, and
7=January.
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Discussion

Amongst the many aspects of Lawsonia intracellularis infections that have been
researched in the years since the bacterium's discovery, maintenance within a population
and spread from animal to animal remains one of the most poorly characterized. Here we
have utilized an ELISA to screen mares and their foals for exposure to L. intracellularis
and examined for a potential effect of seropositive mares on their foals with respect to
seroconversion or the occurrence of clinical EPE/L. intracellularis infection. Based on
results of this study, we were unable to rule out mares as possible sources of L.
intracellularis infection for their foals.
Based on the endemic EPE status of the farm used in this study (Farm 21 in
Chapter 2 and Farm 2 in Chapter 3), as well as work by others that has shown 99% of
adults to be seropositive for L. intracellularis antibodies,108 the fact that only 70.5% of
the mares reported here were seropositive during the study was surprising. Regardless,
the reporting of high L. intracellularis exposure in adult horses continues to suggest
regular exposure of horses, regardless of age, to the bacterium, as well as the potential for
adults to serve as asymptomatic carriers/shedders of L. intracellularis. Further, finding
46.3% of the mare study population to be seropositive for 6 or more months while 13.7%
was seropositive for 10 or more months may indicate either regular exposure or
prolonged exposure to the bacterium, such as would be seen in a carrier state. EPE has
long been known to be a disease of young horses and, while the ELISA used in this study
utilizes a cut-off value validated for use in the at risk population,10,20 it is reasonable to
expect exposure of adults to the bacterium on farms with affected young horses. Given
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that we reported seronegative mares and weanlings towards the end of the study that
seroconverted during the same time period there appears to be no reason to suspect that
the method and cut-off are not valid for use in adult horses. To our knowledge, this is the
first year-long study to serologically follow mares for exposure to L. intracellularis. As
such, this was a pilot study and further sero-screening accompanied by regular fecal PCR
testing of persistently seropositive mares would be useful to further help identify the role
that mares may play in the spread of L. intracellularis on EPE endemic farms.
The steady decline in the overall percentage of study mares that were seropositive
over the 13 month period of the study was unexpected. Based on work with younger
horses, an increase in the overall number of seropositive mares during the fall and winter
months was anticipated. Instead, only a small increase in seropositive mares was noted in
December while a larger peak was noted between July and August. The peak during the
summer is mirrored by a fold-change increase between June and August, as well as a
small increase in first-time mare seroconversions during July and August. The
combination of these findings would seem to suggest that mares may be exposed to L.
intracellularis outside of the "normal" exposure period. While additional data from
subsequent years is needed to confirm these findings, this could have a profound impact
on our understanding of EPE epidemiology.
Supporting the theory that mares play a role in spreading L. intracellularis, we
found that mares with five or more seropositive months through October (the last month
in which foals were weaned) had foals/weanlings that were significantly more likely to
exhibit evidence of exposure to L. intracellularis while mare sero-status had no effect on
the occurrence of presumptive EPE or suspected L. intracellularis infection. Based on
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experimental challenge studies in horses, a 14-21 day incubation period has been
proposed for EPE with seropositive titers typically detected approximately 14 days after
exposure.10,39 However, as presented in Chapter 3, the rate of naturally occurring EPE
cases and L. intracellularis infections amongst exposed horses is significantly lower
(~11% vs. 33-66%) than is seen with experimental EPE models.10,39,57 This difference
likely originates from the large challenge doses that are used to induce clinical disease in
experimental settings. As such, it is feasible that naturally occurring cases are induced by
lower doses, which may exhibit prolonged incubation and seronegative periods. If this
were to be true, mares could be seeding their foal's environment with the bacterium,
leading to detectable seroconversion several months after weaning. However, the large
increase in seroconversions that occurred between December and January in both mares
and weanlings, as well as the large increase in mare EU fold changes during that same
time period would seem to suggest that mares and weanlings were exposed at the same
time, making it unlikely mares are exposing their foals to L. intracellularis. Further, the
lack of an effect of mare seropositivity on the time period during which her foal/weanling
seroconverted also suggests mares may not play a role in exposing young horses to the
bacterium.
The apparent exposure of mares to L. intracellularis during the summer months,
without a concurrent, substantive event in the foal population, may suggest that mares are
actually providing protection to their foals prior to weaning. The most likely mechanism
by which mares would protect their foals would be through immunoglobulin A ingested
by the foal in mare's milk. IgA has been suggested to play a significant role in immunity
to L. intracellularis in pigs given its propensity to accumulate in enterocytes within close
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proximity to the bacterium, as well as the production of mucosal L. intracellularisspecific IgA following experimental infection.89,112 Given that IgA is present within
mare's milk at high concentrations and is complexed with a secretory component that
provides increased resistance to digestion within the gastrointestinal tract,113 milk-derived
IgA could confer immunity to L. intracellularis while foals are nursing. Further,
cessation of milk intake at weaning and beyond would lead to loss of this immunity,
placing the weanlings at risk for the development of EPE. It seems plausible that IgA
could play a significant role in immunity to the bacterium in horses and may warrant
further examination.
This study set out to determine whether mares play a role in the spread and
maintenance of Lawsonia intracellularis on EPE endemic farms and, based on the data,
we were unable to rule-out a role for mares. Further, foals/weanlings from repeatedly
seropositive mares (5 or more seropositive months from parturition to October 2012)
were significantly more likely to exhibit signs of exposure to the bacterium as detected by
an L. intracellularis-specific ELISA. This finding would seem to implicate mares in the
spread of the bacterium, however, there was no effect of mare sero-status on the
occurrence of presumptive EPE or suspected L. intracellularis infection in their foals.
Additional work is needed to replicate naturally-occurring clinical EPE cases to
determine whether the incubation and/or seronegative period is longer than 14-21 days,
as has been reported previously with large-dose, experimental models. Interestingly,
there appeared to be a protective effect of mares on nursing foals during the summer as
there was evidence of mare seroconversion to the bacterium with very little concurrent

109

corresponding seroconversion in foals. One hypothesis for this protective effect could be
milk-derived IgA.

Copyright © Allen Edward Page 2013
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CHAPTER FIVE:
Characterization of the interferon gamma response to Lawsonia intracellularis using
an equine proliferative enteropathy challenge model

Summary

Lawsonia intracellularis is the etiological agent of infectious intestinal
hyperplasia for which several clinical diseases have been described including
proliferative enteropathy (PE), intestinal adenomatosis, and ileitis. While initially
recognized as the causative agent of PE in pigs, L. intracellularis is now viewed as an
emerging cause of intestinal hyperplasia in a wide range of mammalian species, including
horses. Equine proliferative enteropathy (EPE) has been reported worldwide though
definitive diagnosis is difficult and the epidemiology of the disease remains poorly
understood. Weanlings and short yearlings, in particular, appear to be most at risk for
infection, though the reasons for their particular susceptibility is unknown. Using an
infectious challenge model for EPE, we demonstrate that EPE, as in porcine proliferative
enteropathy, can exhibit three clinical forms; classical, subclinical and acute. Out of six
pony weanlings, one developed signs of classic EPE, one developed acute EPE, and two
developed subclinical EPE. Attempts to induce pharmacological stress through the use of
dexamethasone failed to have any effect on outcome. Peripheral blood cells collected
from those weanlings that developed clinical EPE exhibited decreased expression of
interferon-gamma (IFN-γ) following in vitro stimulation with L. intracellularis. By
contrast, those weanlings that did not develop clinical disease generated a robust IFN-γ
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response. These results indicate IFN-γ likely plays a significant role in protection from
disease caused by L. intracellularis in the equid.

This chapter has been previously published and the copyright is held by Veterinary
Immunology and Immunopathology. The manuscript is reproduced here in
accordance with the VII Copyright Agreement. An abstract from this manuscript
was presented at the 2010 American Association of Equine Practitioners Annual
Convention.
Page AE, Loynachan AT, Bryant U, Stills HF, Jr., Adams AA, Gebhart CJ, Pusterla N,
Horohov DW. Characterization of the interferon gamma response to Lawsonia
intracellularis using an equine proliferative enteropathy challenge (EPE) model. Vet
Immunol Immunopathol 2011;143:55-65.
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Introduction

Lawsonia intracellularis, an obligate intracellular, gram-negative rod, is the
causative agent of proliferative enteropathy.1 While initially described as a pathogen of
pigs,4 L. intracellularis is now viewed as an emerging cause of proliferative enteropathy
in a variety of mammalian species,91,92 including horses.14,93-95 In the horse, L.
intracellularis infection results in equine proliferative enteropathy (EPE) which has been
reported worldwide.15,25 The bacterium infects the crypt epithelial cells primarily of the
distal small intestine, causing hyperplasia and proliferation of the infected cells.114
Several possible mechanisms for L. intracellularis pathogenicity have been proposed
including perturbations in cell cycle processes of crypt epithelia; alterations of factors
involved in the differentiation of normally immature and proliferative crypt cells;
disturbances of relevant growth factor receptors; and inhibition of apoptotic cell death in
the crypt.40,41
Typical clinical signs of EPE include anorexia, fever, lethargy, depression,
dependent edema, intermittent colic, and diarrhea. A common diagnostic test used by
many practitioners is abdominal ultrasonography where a small intestinal wall thickness
of >3mm can be considered pathognomonic for EPE when accompanied by compatible
clinical signs; however, false negative results can occur in some cases of EPE.11 The
presence of hypoproteinemia caused by hypoalbuminemia is also highly suggestive of
EPE in weanlings.11 Definitive diagnosis of EPE is based on the presence of histologic
changes and immunohistochemistry of small intestinal sections obtained at necropsy.
Available commercial antemortem tests for EPE consist of fecal L. intracellularis-
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specific PCR and the serum immunoperoxidase monolayer assay (IPMA). Both of these
tests are adapted from their use in pigs where the tests are highly specific. However,
sensitivity is quite variable for the fecal PCR assay.32,34,115 By contrast, sensitivity is
reported to be high for the IPMA,53 though the method is cumbersome, requiring visual
interpretation of the samples. Recently, we have described an L. intracellularis-specific
ELISA for the detection of serum antibodies.20
Cases of EPE are typically seen in weanling horses.11,18,94-96 While the
epidemiology of L. intracellularis is poorly defined, a fecal-oral route of infection is
suspected.46 Several hypotheses exist as for the reason of this age predilection for EPE,
which include a decline in maternal antibodies (see Chapter 3), management changes that
occur during the weaning period, the stress of weaning and changing barns and/or
pastures, as well as implementation of new vaccination and deworming practices.11,18
Additionally, the underdeveloped cell-mediated immunity in younger horses may not be
as capable of combating L. intracellularis compared with adult horses.11
The immunological aspects of EPE remain undefined and recent work has
focused on the antibody response of horses to L. intracellularis.88 However, results from
other animal models indicate that cell-mediated immune mechanisms likely play a pivotal
role in resistance to this infection.54,76 Descriptive immunocytological studies of
intestinal tissue sections of pigs have shown evidence of cell-mediated immune response
to L. intracellularis.4 Oral vaccination of pigs with an avirulent live strain of L.
intracellularis, which is associated with protection from disease,54 results in Lawsoniaspecific IFN-γ expression by PBMC.70 Thus, it appears likely that IFN-γ and other cell-
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mediated immune mechanisms would play a central role in the horse’s immune response
to this bacterium.
Unlike porcine proliferative enteropathy, there had been no established
experimental infection model for L. intracellularis in the equid until recently.39 The pig
infection model has facilitated studies looking at a variety of issues, including vaccine
development,54 comparison of available diagnostic tests,53,116 creation of additional
diagnostic tests,99 and evaluation of feed and feed additives on PPE.117,118 The lack of an
experimental infection model in the horse has left a gap in our knowledge of EPE, with a
large portion of our understanding of the disease adapted from swine research. The
purpose of this study was to experimentally induce equine proliferative enteropathy in
weanlings using a recently isolated and cultivated equine-origin L. intracellularis strain.
Clinical disease was confirmed using available, routine diagnostic techniques, as well as
post-mortem findings. Additionally, we identify a potential role for IFN-γ in protection
from clinical EPE.
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Materials and Methods

Horses
Six nursing pony foals between 16 and 19 weeks of age were selected based on
their close age grouping from the University of Kentucky’s research herd where mares
and foals were maintained on pasture. Prior to the study start (day -7), all six foals were
determined to be healthy on physical exam by a licensed veterinarian with complete
blood count, fibrinogen, and serum biochemistry profiles within normal ranges. At no
time during the study, or in the week prior to challenge, were antimicrobials
administered. The study was approved by the University of Kentucky’s Biosafety and
Institutional Animal Care and Use Committees.

Experimental design
The day prior to challenge (day -1), the foals were weaned and immediately
transported to the Maxwell H. Gluck Equine Research Center where each weanling was
housed separately in an indoor stall for the remainder of the study. Weanlings were
allowed ad libitum water and mixed grass hay. Additionally, each weanling received ¼
quart of sweet feed grain twice a day starting on day +2 as a means of detecting partial or
total anorexia. Each foal received omeprazole M (4mg/kg, q 24h, PO) from day -7
through day +2. An additional fifteen pony foals of approximately the same age remained
at the farm for the duration of the challenge study serving as serological controls only and
were not euthanized or necropsied at the end of the study.

M
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Immune suppression assessment
Immune suppression was induced using physiologic stress (weaning) and
pharmacologic methods. The first involved weaning the foals on the day prior to
challenge. Recent work in our laboratory has shown that the stress of weaning is
significant enough to cause a decrease in cell-mediated immunity.80 Additionally, three
of the six weanlings (1, 3, and 5) were randomly assigned to be administered
dexamethasone N at 0.25mg/kg, q 24 h, IV on day -1, 0.125mg/kg, q 24 h, IV on days 0
and +1, and 0.04mg/kg, q 24 h, IV on day +2. To assess immune suppression, peripheral
blood (~3.0 mls) was collected directly into Paxgene O tubes prior to weaning and daily
afterwards for the determination of nascent expression of IFN-γ mRNA.78 Total RNA
was isolated from the Paxgene tubes according to the manufacturer’s directions and the
RNA converted to cDNA using avian leukosis virus reverse transcriptase.119 Cytokinespecific cDNA was amplified using real-time PCR and primers and probes specific for
IFN-γ. Beta-glucuronidase was used as the housekeeping gene for RNA normalization.78
The efficiency of the PCR reaction was confirmed using LinReg.120 Results are
expressed as relative quantities121 with the average of pretreatment blood samples used as
the calibrator.
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Live-cultured Lawsonia intracellularis and challenge
Low passage, equine-origin L. intracellularis was grown by GBI Laboratories P,
using previously described methods.6,39 Using the direct-count method,37 the number of
organisms was found to be 4.45x108/ml. The inoculum was stored at -80oC until the day
prior to challenge (day -1), when the entire sample of L. intracellularis was placed into a
4oC refrigerator to thaw slowly overnight. On day 0, 45mL of live L. intracellularis was
placed into six individual 60cc catheter-tipped syringes. The six pony weanlings were
then challenged with the equine-origin L. intracellularis (2x1010 organisms/weanling) via
nasogastric intubation. No weanlings were sedated for this process and feed was not
withheld pre- or post-inoculation.

Monitoring of physical health
The six weanlings were monitored daily for pyrexia (>101.5oF), anorexia, colic,
dependent edema, and diarrhea. Additionally, each study weanling was weighed and an
abdominal ultrasound was performed weekly.

Antemortem diagnostic testing
On days -16 and -7 all six foals, as well as controls, tested negative for the
antibodies to L. intracellularis via ELISA. Testing involved collecting 7ml of whole
blood via jugular venipuncture into sterile 7 ml plain blood tubes. Blood was allowed to
clot for 1-2 hours, after which time the tubes were centrifuged at 800xg for 10min. 1ml
of serum was removed and placed into individual 1.5ml tubes that were labeled with the
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horses’ ID number and date of collection. Samples were frozen at -20oC until analyzed
via ELISA. The method for this ELISA is provided in Chapter 2.
Fecal samples were collected from each weanling from day 0 through day +6 and
biweekly thereafter. Each sample was stored in a separate, labeled 50ml conical tube at 20oC until a batch of samples was shipped overnight in cooler boxes to the University of
California, Davis for real-time PCR detection of the aspartate ammonia lyase (aspA)
gene of L. intracellularis as previously described.46 Biweekly blood samples were
collected and submitted for total protein (ref: 5.3-7.5 g/dL) and albumin (ref: 3.0-4.0
g/dL) levels. Serum total protein and albumin levels were obtained using an ACE Alera
at the University of Kentucky’s Veterinary Diagnostic Laboratory.

In vitro stimulation of peripheral blood, RNA isolation, storage, processing, and
analysis
Green-top, lithium heparin blood tubes were collected from each weanling via
jugular venipuncture on days -7, 0, +7, +14, +21, and +28 (when available). To each of
the three tubes was aseptically added nothing (“control”), 10µl phorbol 12-myristate 13acetateQ (PMA; 25 ng/ml) and ionomycin (1 mM; Sigma), or 250uL modified-live L.
intracellularis vaccine R. Tubes were then placed into a 37oC humidified incubator for 24
hours. After 24 hour incubation, 2.5 mL of blood was removed from each tube and
placed into a corresponding PaxGene tube. Total RNA isolation and subsequent
processing were completed per the manufacturer’s directions.
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Euthanasia and post-mortem evaluation
All six weanlings were to be humanely euthanized at the end of the four week
study (day +29); however, the severity of clinical disease in two of the weanlings (1 and
4) necessitated their euthanasia on day +21. Immediately following euthanasia, all six
weanlings had full necropsies performed by boarded and board-eligible pathologists at
the University of Kentucky’s Veterinary Diagnostic Laboratory. Mucosal scrapings from
each weanling’s ileum were sent to the University of California, Davis for L.
intracellularis-specific PCR testing, as above. Immunohistochemistry was utilized to
detect the presence of L. intracellularis in the intestinal tract. The presence of the
challenge strain of L. intracellularis obtained from necropsy samples was confirmed
through the use of variable number tandem repeat (VNTR) analysis, as previously
described.122

Immunohistochemistry
Tissue sections were stained using the EnVision+ Dual Link System-HRP S
immunohistochemical staining technique. Briefly, paraffin embedded tissue sections
were placed on electrostatically charged glass slides, deparaffinized with xylene, and
rehydrated. Endogenous hydrogen peroxide was quenched by applying a 3% hydrogen
peroxide solution for 10 minutes. Slides were then rinsed with deionized water 3 times.
Antigens were retrieved by adding 0.05% protease K to the tissues for 2 minutes, and
then slides were re-rinsed an additional 3 times with deionized water. A 1:500 dilution of
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L. intracellularis-specific monoclonal antibodyT was added to the slides for 45 minutes
after which slides were rinsed with Tris-buffered-saline (TBS). A polymer conjugated
with secondary antibodies was then applied to the tissue, allowed to incubate for 30
minutes, and then washed with TBS. Slides were incubated for 5 minutes with a
substrate-chromogen solution and then were cover slipped. Tissues were finally analyzed
for the presence or absence of L. intracellularis specific staining by light microscope.
Negative controls consisted of both a negative reagent control and negative tissue
control. The negative reagent control was performed by the procedure listed above with
the exception that the primary monoclonal L. intracellularis antibody was substituted
with a universal negative control mouse antibody (product #N1698, Dako North
America, Inc.). Ileum from a single age-matched foal, which was euthanized for
neurologic disease, was used as the negative tissue control.

Case Definition
After the conclusion of the study, weanlings were classified into three different
categories (clinically affected, subclinically affected, and non-affected) based on the
severity of observed clinical signs, the severity of clinicopathologic abnormalities,
consistent fecal shedding of L. intracellularis as determined by fecal PCR for the aspA
gene (as described above), the presence of gross or histologic changes consistent with
EPE (pronounced rugation of the ileum and/or mucosal hyperplasia), and the presence or
absence of L. intracellularis organisms in the distal small intestine as determined by
immunohistochemistry and/or PCR for the organism on mucosal scraping samples. Due
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to the shortened nature of this study, ELISA unit values were not considered when
categorizing the weanlings. Weanlings were considered to be clinically affected with
EPE when they experienced all of the following: overt clinical signs compatible with
EPE, moderate to severe hypoproteinemia and hypoalbuminemia (less than 5.0 g/dl and
2.5 g/dl, respectively), more than two consecutive fecal samples PCR positive for L.
intracellularis, and gross ileal mucosal proliferation with confirmed presence of L.
intracellularis organisms either by IHC or PCR. Overt clinical signs were defined as the
presence of two or more clinical signs compatible with EPE (anorexia, lethargy,
depression, dependent edema, fever, colic, and diarrhea). Weanlings were considered to
be subclinically affected if they did not experience all of the criteria listed for clinically
affected weanlings. Non-affected weanlings were defined as those with none of the
criteria listed for clinically affected weanlings.

Data analysis
Two-way repeated measures-analysis of variance (RM-ANOVAs) (Holm-Sidak
method U) was used to evaluate IFN-γ gene expression. Post hoc t-tests were performed
to evaluate the differences between groups at each time point. Calculated P values <0.05
were considered to be statistically significant.

U

SigmaStat, SPSS Inc., Chicago, IL
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Results

The effect of weaning and dexamethasone treatment on IFN-γ production
Due to treatment randomization, the dexamethasone-treated foals had higher
nascent IFN-γ mRNA expression prior to treatment; nevertheless, weaning significantly
suppressed IFN-γ mRNA expression in both groups (Figure 5.1). This suppression was
further exacerbated by treatment with dexamethasone on days 1 and 6.

Clinical signs, clinicopathologic changes, and necropsy findings
None of the control ponies demonstrated overt clinical signs compatible with EPE
during the study or the two month period following the conclusion of the study. Overall,
out of the six weanlings that were challenged with L. intracellularis, four weanlings (1, 2,
3, and 4) were ultimately diagnosed with EPE based on the combination of clinical signs,
clinicopathologic findings, histologic changes, or PCR results (Table 5.1). Treatment
with dexamethasone had no effect on clinical outcome as each of the treated ponies fell
into one of the outcome groups (clinical, subclinical, and non-affected).
Weanling #1 exhibited signs of classic EPE including hypoproteinemia (Figure
5.2) and hypoalbuminemia (Figure 5.3). For welfare reasons, this weanling was
euthanized on day 21. Histological examination at necropsy revealed elongated ileal villi
and blunted, frequently branching crypts. Weanling #4 was the other clinically affected
weanling; this weanling’s condition declined acutely leading to euthanasia on day 21. On
necropsy, the ileum and distal jejunum were mildly to moderately proliferative and
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Figure 5.1: Weaning and dexamethasone treatment suppressed nascent IFN-γ
mRNA expression. Results are expressed as relative quantity (RQ) with the average
of the day -7 samples used as the calibrator and time points significantly different
(p<0.02) from d-7 are denoted with “#”. Significant differences (p<0.05) between
treated and non-treated weanlings at each time point are designated “*”.
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Table 5.1: Gender, clinical signs, serum total protein and albumin levels, fecal PCR status, and ultrasonographic findings for
each horse and the first day that the finding occurred, if applicable.
Low Alb?

PCR +
feces?

U/S SI
thickening?
Size?

Mucosal
Proliferation

Y, D16

Y, D16

Y, D13

Y, 5mm, D20

None

Y, D20

Y, D20

Y, D13

Low TP?

None

Rugation

IHC

Clinical EPE
Status*

Mild

Mild

+

+

Clinical

None

Mild/Mod

Mild/Mod

+

+

Clinical

Gender

Anorexia?

Edema?

1***

Filly

Y, D13

Y, D17

4

Filly

Y, D19

No

2

Filly

No

No

None**

None

Y, D23

Y, D23

Y, D16

Y, 5mm, D20

Mild

Mod

+

-

Subclinical

3***

Colt

No

No

None

None

Y, D29

No

No

None

Mild/Mod

Mod

+

+

Subclinical

5***

Colt

No

No

None

None

Y, D16

No

No

None

Min/Mild

Min

-

-

Non-affected

Mild

Mild

-

-

Non-affected

Horse #

Colic or
Diarrhea?

Mucosal
Scrapings
PCR

Febrile?
Temp?
Y, 101.7F,
D21
Y, 104.1F,
D20*

Colt
No
No
None
None
Y, D23
No
No
None
6
Y=Yes, D= Day, TP= total protein, Alb= albumin, U/S= ultrasound, IHC= immunohistochemistry, Min= minimal, Mod= moderate
Horses are ordered based on clinical status
*"Clinical EPE Status" refers to those ultimately classified as clinically affected, subclinically affected, or non-affected
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** Mildly febrile on D-1- attributed to stress of relocation and weaning
*** Treated with dexamethasone
Low TP ≤5.3 mg/dL
Low Albumin <3.0 mg/dL
Febrile >101.5F
Normal SI size ≤3mm

126
Figure 5.2: Serum total protein levels in L. intracellularis challenged weanlings.
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Figure 5.3: Serum albumin levels in L. intracellularis challenged weanlings.

rugated. Histologically, areas of mucosal necrosis and crypt herniation with branching
were noted, as well as hyperplasia of the crypt epithelium (Figure 5.4). Additionally,
both IHC (Figure 5.5) and mucosal scrapings PCR were positive for the bacterium.
Subsequent testing for other causes of severe, acute necrotizing enteritis, including
Salmonella sp. (both direct and enrichment broth culture), Clostridium perfringens, C.
difficile, and Neorickettsia risticii was negative. Both weanlings #1 & 4 experienced
weight loss during the course of the study, compared with the other four weanlings
(Figure 5.6).
Weanlings #2 & 3 were diagnosed with subclinical EPE based on the absence of
all of the required criteria to be classified as clinically affected. Weanling #2
demonstrated a mild, transient decrease in total protein and albumin levels beginning on
day 23 (Figures 5.2 and 5.3), in contrast to the more profound decrease seen in the
clinically affected group. While this weanling did test fecal PCR positive for L.
intracellularis on days 16 and 20 it was consistently a weak positive. No L.
intracellularis organisms were detected by IHC; however, the bacteria were detected by
mucosal scrapings PCR. By comparison, weanling #3 demonstrated no signs of EPE and
no feces tested PCR positive for aspA. However, the ileal mucosa was mildly to
moderately proliferative and exhibited moderate rugation. Additionally, IHC
examination of the distal ileum revealed positive staining for L. intracellularis within the
enterocytes and mucosal scrapings PCR returned a positive result. While weanlings #2
and 3 had net weight gains during the study, their weight gain was less than that achieved
by weanlings #5 and 6 (Figure 5.6).
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(a)

(b)
Figures 5.4 a & b: Representative photomicrographs of ileal sections from an agematched control and infected weanlings. (a) Normal small intestinal histology
(mag=10x), (b) Ileal histologic section from weanling #4, showing marked epithelial
hyperplasia as well as branching of the crypts (mag=10x).
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(a)

(b)
Figures 5.5 a & b: Immunohistochemistry detection of L. intracellularis. (a)
Negative control small intestine (mag=40x), (b) Representative staining of ileal
section from weanling #4 showing positive staining in the crypt epithelial cells for L.
intracellularis. (mag=40x)
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Figure 5.6: Net percent weight change for each weanling.
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Neither weanling #5 nor weanling #6 demonstrated any signs of EPE;
additionally, feces from both weanlings tested PCR negative for L. intracellularis. On
necropsy, both weanlings had minimal to mild ileal mucosal proliferation with mild
rugation of the distal ileum. No L. intracellularis organisms were detected in either
weanling using IHC or PCR of the mucosal scrapings. Both of these weanlings achieved
the highest weight gains over the course of the study (Figure 5.6).

Lawsonia intracellularis-specific ELISA
The average L. intracellularis-specific ELISA value for the 15 serological control
ponies was 33EU, with a standard deviation of 7EU with a maximum ELISA of 49EU
and a minimum of 22EU. The control ponies remained ELISA negative through the last
day of the study. Based on these controls, an ELISA value > 55EU (serological control
mean plus 3 standard deviation units) was considered positive. Of the two clinically
affected weanlings, weanling #1’s first positive ELISA test (56 EU) occurred on day 6
and the values continued to increase until the day of euthanasia, day 21 (Table 5.2). In
comparison, weanling #4’s first positive ELISA value was on day 20. From the two
subclinically affected weanlings, weanling #2’s first positive ELISA value was first
detected on day 20 and increased through day 29, while weanling #3’s initial positive
value was detected on day 13 and increased slowly until the end of the study. Both nonaffected weanlings seroconverted on day 13 and remained seropositive through the end of
the study (day 29).
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Table 5.2: ELISA unit values for each horse in relationship to the day of challenge
with L. intracellularis. Positive samples are denoted with a *. NS= No Sample
Horse
#
Day -7 Day 0
Day 6 Day 13 Day 20 Day 21 Day 27 Day 29
#1
31
36
*56
*106
NS
*394
NS
NS
#2
39
30
44
32
*538
NS
*425
*746
#3
36
34
37
*141
*235
NS
*267
*452
#4
38
32
34
52
*368
*400
NS
NS
#5
27
26
27
49
*198
NS
*148
*186
#6
22
34
22
27
*241
NS
*202
*227
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In vitro stimulation of whole blood with L. intracellularis
Interferon-gamma mRNA expression data in response to whole blood stimulation
with L. intracellularis are presented in Figure 5.7. The clinically affected weanlings
produced significantly (p<0.001) less IFN-γ mRNA following antigen stimulation than
the other weanlings on day 20. A similar, though non-significant, difference was also
seen on day 13 post-challenge. There were no significant differences between the groups
in terms of their IFN-γ mRNA expression in response to PMA-ionomycin (data not
shown).
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Figure 5.7: L. intracellularis-induced IFN-γ production by peripheral blood cells.
Results are expressed as relative quantity (RQ) with unstimulated control samples
used as the calibrator.
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Discussion

As an emerging disease of horses, the development of an effective and reliable
challenge model for equine proliferative enteropathy is critical to further our
understanding of this disease. This is particularly true with respect to developing new
and improved diagnostics, as well as understanding the pathogenesis and immunology of
EPE. These are the first results published from a Lawsonia intracellularis challenge in
equids with infection confirmed by postmortem examination, demonstrating that equine
proliferative enteropathy can exhibit three clinical forms. As such, one weanling
demonstrated signs of classical EPE, another showed clinical signs and histological
changes compatible with acute PPE (“acute EPE”), and two others exhibited signs of subclinical disease. The remaining two weanlings seroconverted, but exhibited no clinical or
pathological signs indicating that they successfully cleared their infections.
With respect to porcine proliferative enteropathy, three different forms have also
been identified: 1.) chronic, 2.) subclinical, and 3.) acute. In the chronic form, the most
common signs are diarrhea, rough hair coat, decreased feed consumption, and reduced
weight gain.123 In subclinically infected pigs, the most common clinical sign is poor
weight gain,123 with younger pigs typically affected.124 The acute form of PPE usually
affects older pigs, with severe intestinal hemorrhage, fever, and sudden death being the
most common clinical signs,123 though necrotizing enteritis can be seen with cases of
acute porcine proliferative enteropathy.125
This is the first study to document successful induction of EPE confirmed by
postmortem findings. Possible reasons for the success of this model include the large
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inoculation dose used for each horse (4.45x108/ml or 2x1010 organisms per pony), as well
as the use of pony weanlings rather than horse weanlings. This led to a larger
concentration of L. intracellularis organisms/kg of body weight than if horse weanlings
had been used. In pigs, an infectious dose of 104-106 has been suggested as infective.126
While the natural infectious dose needed to induce EPE in the horse is unknown, their
larger body size, greater intestinal volume, and differences in the gastro-intestinal
environment could account for the higher dose requirement. Additionally, it is also
possible that natural infection occurs through repeated exposure to lower doses rather
than a single, large bolus dose. Since all of the weanlings seroconverted in this study, it
seems likely that our challenge dose was sufficient to cause infection. Corticosteroids
were unlikely to have contributed to disease induction in this study since of the four
affected weanlings, two were treated with dexamethasone and two were not. A more
likely reason for the success of this model is that challenge coincided with the weaning
period and the associated stress likely impacted cell-mediated immunity. Indeed, all foals
exhibited depressed nascent IFN-γ mRNA expression in response to weaning.
Dexamethasone treatment further diminished the IFN-γ response, yet there was no effect
of this added suppression on clinical outcome. Either weaning alone provided sufficient
reduction of cellular immunity for the infection to develop or depression of nascent IFN-γ
mRNA expression played little role in the susceptibility of the weanlings to infection.
Results from other animal models indicate that cell-mediated immune
mechanisms likely play a pivotal role in resistance to L. intracellularis infection.54,76
Descriptive immunocytological studies of intestinal tissue sections of pigs have shown
evidence of cell-mediated immune response to L. intracellularis.4 Peripheral blood
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mononuclear cells from infected pigs exhibit increased production of L. intracellularisinduced IFN-γ post challenge.70 Similarly, studies in mouse models have identified a
significant role for IFN-γ in protective immunity to L. intracellularis.74,76 Genetic
mapping studies in horses suggest a similar role for IFN-γ,127 though no direct
demonstration has yet been provided. Here we show an association between the IFN-γ
response following in vitro stimulation of peripheral blood with L. intracellularis and
clinical outcome. Peripheral blood from the two weanlings that succumbed to the
challenge infection produced significantly less IFN-γ compared to the surviving
weanlings after incubation with L. intracellularis. Thus, it appears likely that IFN-γ and
other cell-mediated immune mechanisms play a central role in the horse’s response to
this bacterium.
The precise contribution of cell-mediated immunity to protection against
EPE is also somewhat unclear. Since L. intracellularis replicates in the intestinal
epithelium it could induce a cellular cytotoxic immune response against the infected
cells, as is the case for other intracellular microorganisms.76 However, L. intracellularis
infection are generally associated with modest cellular infiltration,74 therefore a direct
effect of IFN-γ on cellular proliferation is thought to be the likely mechanism of
action.74,76 A similar mechanism of action is seen in other intracellular infections, as
well.128,129 Oral vaccination of pigs with an avirulent live vaccine of L. intracellularis is
associated with protection from disease54 and the induction of IFN-γ by L. intracellularisstimulated PBMC.89 The robust IFN-γ recall response we observed in those weanlings
that were protected from clinical infection indicates a similar protective role for this
cytokine in EPE.
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CHAPTER SIX:

Conclusions and Future Research Directions

As an emerging disease of horses, there are many answered questions that revolve
around equine proliferative enteropathy. Unfortunately, because of the relative rarity
with which EPE occurs outside of central Kentucky, and even amongst exposed horses
for that matter, all but the most basic of studies into EPE have yet to be performed. The
research presented within this dissertation utilized the tremendous resource central
Kentucky Thoroughbred farms provide to offer additional insight into why EPE occurs
sporadically despite high exposure rates.

All farms in central Kentucky experience exposure to L. intracellularis and previous
EPE suggests future risk
Perhaps one of the most surprising findings from this research came from Chapter
2, in which all farms, regardless of their prior EPE history, had evidence of
weanling/yearling exposure to L. intracellularis. Given the other finding from that
chapter in which prior history of EPE was associated with an increased seroprevalence
rate, as well as a likelihood of developing disease in subsequent years, possible
explanations for the differences between the groups would be L. intracellularis strain
pathogenicity, exposure burdens, or a combination of the two. Titration challenge
studies, much like those that have been performed in pigs,50 would help to elucidate
whether there are differences in disease occurrence and antibody levels between dosages
while experimental challenge with different strains of the bacterium would show whether
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there truly are strain differences. Given that there is currently only one known isolated
strain of equine-origin L. intracellularis available for use, this second part is currently not
possible. An alternative might include regular collection of fecal material from the atrisk population followed by genetic typing122 of the bacterium to look for similarities and
differences on farms with endemic versus no EPE.

Passively-acquired antibodies to L. intracellularis do not protect against EPE
It is not surprising, given the enteric location of L. intracellularis infection, that
passively-acquired and systemically circulating antibodies do not have a protective role
against EPE, despite a recent suggestion to the contrary in pigs.68 A larger number of
EPE cases would have helped to strengthen these conclusions especially given the lowerthan-expected number of mares that were seropositive at parturition. However, given that
the rates of disease and infection and foal seropositivity following parturition were
similar, there is little reason to question the findings presented here.

Disease "attack" rates of ~11% can be expected in L. intracellularis-exposed horses
Traditionally, estimates of 5-10% of seropositive horses developing clinical EPE
have been used, but this assumption has never been proven in a large scale, field study
before. With L. intracellularis-exposed horses, we found a clinical EPE attack rate
(using the presumptive EPE cases) of 5.3% and an infection attack rate (using cases with
suspected infections) of 6.3%; combined, the overall attack rate was 11.6% among
seropositive horses. An accurate attack rate will allow for refinement of experimental
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challenge models and testing of numerous hypotheses with respect to EPE epidemiology
and disease susceptibility.

Mares cannot be ruled out as playing a role in the epidemiology of EPE
Given the amount of time that foals spend with their respective mares prior to
weaning, as well as the relatively high number of mares that were seropositive for 6+
months (46.3%), mares must be regarded as a potential source of L. intracellularis for
their foals. The data in this study did not eliminate mares as possible sources of the
bacterium on an EPE-endemic farm. Since this was a pilot study, further serum screening
accompanied by regular fecal PCR testing of persistently seropositive mares and all
foals/weanlings on an endemic farm will be necessary to identify what role mares play in
the spread of L. intracellularis. Because of the rarity with which nursing foals develop
EPE, one of the possibilities is that mares, through milk-derived IgA, are protecting their
foals from exposure and disease. This idea could be easily tested by weaning nursing
foals and comparing their EPE susceptibility with that of nursing, non-weaned foals.

IFN-γ plays a significant role in protection against the development of EPE
This was the first study in any of the main target species to correlate L.
intracellularis-induced IFN-γ production with disease protection. As has been mentioned
earlier, IFN-γ seems the most likely effector of CMI in response to L. intracellularis
infection and here we showed that failure to produce IFN-γ in response to infection may
have ultimately led to the occurrence of EPE. Given that IFN-γ production increases with
age in horses,78 one possible experiment would entail challenging neonates, foals,
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weanlings, yearlings, and adults with L. intracellularis. It would then be possible to
correlate their IFN-γ response in vitro to the bacterium with the presence of infection
and/or disease as detected on necropsy. Likewise, with recent work from our lab
showing that a dirty barn atmosphere is capable of stimulating an increase in IFN-γ+
lymphocytes, as well as work in pigs showing a markedly higher disease rate amongst
challenged pigs, another experiment could examine the difference in disease rates
between foals/weanlings raised only in pastures, a dirty barn, or a "clean" barn. Lastly,
given the suggestion in Chapter 3 that prior Rhodococcus equi infection may protect
against clinical EPE, a two-tiered challenge study (first, as foals with R. equi, followed by
challenge, as weanlings, with L. intracellularis) would be useful to determine whether
this relationship does exist and the potential mechanisms for it.

Other directions
As elucidated in Chapter 1, L. intracellularis appears to be capable of avoiding
multiple arms of the immune system given the lack of an inflammatory response
following infection. With our recent reporting of N-EPE cases, in addition to PHE cases,
it is possible that these occur because the bacterium is detected via the CMI or innate
immune system, or Tregs fail to down-regulate the localized immune response. Given
that TGF-β is important for suppression of Th1 and Th2 function, the differentiation of
inducible Tregs, and has been shown to increase following infection with L.
intracellularis68, TGF-β knockout mice could possibly be used to examine its role in the
pathology of L. intracellularis infection. If TGF-β is important in limiting overt
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inflammation following infection with the bacterium, we would expect to see pathology
similar to N-EPE or PHE in these mice.

This dissertation has provided both novel data as well as data to show that L.
intracellularis infection and disease in horses is similar to what has been reported in other
species. This all serves to provide the building blocks for future work into EPE from
both epidemiology and immunology standpoints as a better understanding of L.
intracellularis and its mechanisms of disease induction and immune evasion is necessary
to develop strategies for combating and preventing equine proliferative enteropathy.

Copyright © Allen Edward Page 2013
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APPENDIX I:
Graph of Standard Curve Optical Density (OD) Values for Each Lawsonia intracellularis-Specific ELISA Unit Value
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APPENDIX II:
Acute Deterioration and Death with Necrotizing Enteritis Associated with Lawsonia
intracellularis in Four Weanling Horses

This chapter has been previously published and the copyright is held by the Journal
of Veterinary Internal Medicine. The manuscript is reproduced here in accordance
with the JVIM Copyright Agreement.
Page AE, Fallon LH, Bryant UK, et al. Acute deterioration and death with necrotizing
enteritis associated with Lawsonia intracellularis in 4 weanling horses. J Vet Intern Med
2012;26:1476-1480.

Cases

Case 1:
An 8-month-old Thoroughbred colt was evaluated in October 2010 with a lessthan-one-day history of inappetence. Physical examination in the field revealed throat
latch edema, depression, and a fever (103.8oF) (ref 99-101.5 oF). A complete blood count
revealed leukocytosis (18.0 K/uL; ref 5.0-12.6 K/uL) with a relative neutropenia (49%;
ref 55-65%) and lymphopenia (26%; ref 35-45%), as well as a toxic left shift (25%
bands; ref 0-5%). Serum biochemistry abnormalities included hypoproteinemia (3.3
g/dL; ref 6-7.9g/dL), hypoalbuminemia (1.2 g/dL; ref 3.4-4.1 g/dL), and an increased
BUN (45 mg/dL; ref 11-26 mg/dL), along with other abnormalities (Table A.1).
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Table A.1. All available blood work results. Day 0= day initial signs of EPE were noted. Reference ranges are provided for
each parameter in ( ).
Case
#2 Day
0
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WBC (5-12.6 K/ul)
RBC (6.5-9.99 M/ul)
HGB (11-16 g/dL)

Case #1
Day 0
18.0 (H)
12.9 (H)
15.3

Case #1
Day +2
35.4 (H)
10.8 (H)
12.8

Case #2
Day +3
1.6 (L)
16.5 (H)
21 (H)
63.9%
(H)
644 (H)
18% (L)

Case #3
Day +3
31.5 (H)
15.18 (H)
19.9 (H)
50.4%
(H)
700 (H)
78% (H)

Case #3
Day +4
42.4 (H)
8.17
10.7 (L)

Case #4
Day +1
7.7
9.64

HCT (33-48%)
PLT (115-450 K/uL)
Neut (55-65%)

44.8%
600 (H)
49% (L)

45%
508 (H)

Bands (0-5%)
Lymph (35-45%)
Mono (0-6%)
Na (133-140 mEq/L)
K (2.5-5 mEq/L)
Cl (97-105 mEq/L)
CO2 (25-32 mEq/L)
Anion Gap
BUN (11-26 mg/dL)
Creatinine (0.8-1.8
mg/dL)
Calcium (11.6-13.2
mg/dL)
Total Protein (6-7.9 g/dL)
Albumin (3.4-4.1 g/dL)

25% (H)
26% (L)
0%
122 (L)
3.4
90 (L)
19 (L)
13
45 (H)

39.2%
83 (L)
49% (L)
26%
(H)
25% (L)
0%
115 (L)
3.2
86 (L)
14 (L)
15
59 (H)

27.4% (L)
125
76% (H)

34.9%

134
3.9
97
25
12
32 (H)

12% (H)
70% (H)
0%
123 (L)
3.3
89 (L)
17 (L)
17
50 (H)

15% (H)
7% (L)
0%
118 (L)
3.3
85 (L)
20 (L)
13
33 (H)

9% (H)
15% (L)
0%
125 (L)
4.4
100
20 (L)
5
47 (H)

0
84 (H)
2
133
4.0
92 (L)

1.3

1.8

1.2

2.4 (H)

1.4

1.9 (H)

0.7 (L)

9.1 (L)
3.3 (L)
1.2 (L)

12.6
3.5 (L)
1.1 (L)

9.6 (L)
5.1 (L)
2.5 (L)

8.5 (L)
3.7 (L)
1.5 (L)

8.0 (L)
2.3 (L)
0.9 (L)

8.2 (L)
1.7 (L)
0.6 (L)

3.6 (L)
1.8 (L)

2.8 (L)

Case #2
Day +1
6.2
11.3 (H)
15.1

14 (L)

4.7 (L)

Lawsonia intracellularis-induced equine proliferative enteropathy (EPE) was suspected
because of the combination of hypoproteinemia, hypoalbuminemia, inappetence, and the
autumn presentation. Treatment consisted of intravenous oxytetracycline V (6.6 mg/kg IV
q24hr), flunixin meglumine W (1 mg/kg IV q12h), oral omeprazole X (1 mg/kg PO q24hr),
dexamethasone Y (0.1 mg/kg IV q24hr), intravenous crystalloid fluids Z (10 ml/kg IV
bolus once), and intravenous colloids AA (10 ml/kg IV bolus once). Despite treatment, the
weanling was euthanized within 48 hours of presentation due to continued deterioration
and signs of pulmonary disease characterized by nasal discharge, epistaxis, and
tachypnea. Blood work submitted the morning of euthanasia revealed a worsening
leukocytosis (35.4 x103/uL) with an unchanged differential, as well as continued
hypoproteinemia (3.5 g/dL), hypoalbuminemia (1.1 g/dL), and an increased BUN (59
mg/dL).

Case 2:
An 8-month-old Thoroughbred filly from the same farm as case #1 presented in
October 2011 with inappetence of less than 12-hours duration. Physical examination
revealed fever (102.5oF) and an unthrifty appearance, including a poor hair coat.
Examination of the serum albumin concentration at presentation revealed
hypoalbuminemia (2.8 g/dL). A complete blood count the following morning revealed
no significant abnormalities, but hypoproteinemia (5.1 g/dL) and a worsening

V

Liquamycin LA-200, Pfizer Animal Health, New York, NY
Banamine, Merck Animal Health, Summit, NJ
X
UlcerGard, Merial Ltd., Duluth, GA
Y
Dexium, Bimeda, Le Sueur, MN
Z
Normosol-R, Hospira, Lake Forest, IL
AA
Hetastarch, Hospira, Lake Forest, IL
W
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hypoalbuminemia (2.5g/dL) were seen on serum biochemistry; additionally, an L.
intracellularis immunoperoxidase monolayer assay (IPMA) titer of ≥1:240 was reported.
Other abnormalities were also noted (Table A.1).

On the basis of the time of year, the

presence of anorexia, hypoproteinemia, hypoalbuminemia, and the weanling’s positive
IPMA titer, in addition to the farm’s previous history, a presumptive diagnosis of EPE
was made. Treatment initially consisted of oral doxycycline BB (10 mg/kg PO q12h) and
flunixin meglumine (1 mg/kg IV q12h); however, due to the continued decline of the
weanling, the doxycycline was discontinued and intravenous oxytetracycline (6.6 mg/kg
IV q24hr) initiated two days after presentation.
The following morning (approximately 60 hours after initial signs were noted),
the filly was depressed and lethargic, with a fever of 105.9oF. CBC revealed severe
leukopenia (1.6 x103/uL), neutropenia (18%), lymphocytosis (70%), and toxic left shift
(12%). The serum biochemistry abnormalities included azotemia as well as a decline of
serum total protein (3.7 g/dL) and albumin (1.5 g/dL)(Table S1). Concerns about the
filly’s condition prompted referral for more intensive care. On arrival, the filly remained
depressed and lethargic with a fever of 103.1oF. Additionally, the filly was tachycardic
(78 bpm; ref 20-44 bpm) and tachypneic (48 bpm; ref 8-24 bpm). Abdominal ultrasound
revealed thickened small intestinal wall (6mm; ref ≤3mm) and free fluid in the abdominal
cavity. Abdominocentesis was performed, and fluid analysis revealed a WBC count of
77,500 cells/uL (90% neutrophils and 10% mononuclear cells) (ref 0.5 - 5.0x103/uL
WBC and 1:1 ratio of neutrophils:mononuclear cells) and total protein of 2.0 g/dL (ref

BB

Hagyard Pharmacy, Lexington, KY
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0.5-1.5 g/dL). In addition, a moderate number of short Gram-negative rods and rare
Gram-positive cocci were noted, but no plant or fecal material was seen in the peritoneal
fluid sample. Culture results of the abdominal fluid revealed Actinobacillus equuli.
Within several hours of hospitalization, the filly became agitated, developed cyanotic
mucous membranes, and exhibited agonal activity. The filly was euthanatized
approximately 72 hours after initial presentation at the farm.

Case 3:
A 6-month-old Thoroughbred colt was evaluated on the farm in November 2011
due to a 72-hour history of lethargy. On presentation, the colt was lethargic, tachycardic
(68 bpm), and febrile (103.5oF). Additionally, the colt had dark red/purple mucous
membranes and delayed capillary refill time. The colt had developed diarrhea within the
previous 12 hours, and severe throatlatch and preputial edema were noted. Immediately
prior to referral to the McGee Medicine Center, treatment was initiated at the farm and
included intravenous oxytetracycline (6.6 mg/kg IV q24hr), flunixin meglumine (1 mg/kg
IV q12h), and synthetic colloids (10 ml/kg IV bolus once). A complete blood count
indicated leukocytosis (31.5 x103/uL) with neutrophilia (78%), lymphopenia (7%), and a
left shift (15%). Serum biochemistry abnormalities included hypoproteinemia (2.3 g/dL)
and hypoalbuminemia (0.9 g/dL), along with other metabolic abnormalities (Table S1).
Abdominal ultrasound demonstrated thickening of the small intestinal wall and a
preliminary diagnosis of EPE was made.
Following referral, the colt remained febrile despite non-steroidal antiinflammatory drug (NSAID) treatment; further, epistaxis developed, with progressively
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increasing volumes of blood exiting both nostrils, ultimately leading to respiratory
distress. The respiratory distress was partially alleviated with the placement of a
nasotracheal tube. Spontaneous epistaxis continued and the colt also began passing
dark/bloody diarrhea and blood tinged urine. Because of welfare concerns in the face of
suspected disseminated intravascular coagulation (DIC), the colt was euthanized less than
96 hours after developing clinical signs. Blood work values collected prior to euthanasia
revealed an increased leukocytosis (42.4 x103/uL), as well as a progressive
hypoproteinemia (1.7 g/dL) and hypoalbuminemia (0.6 g/dL) (Table S1).

Case 4:
A 6-month-old Thoroughbred colt presented in late October 2011 with a fever
(105oF) five hours prior to initial evaluation; the fever was immediately treated by the
farm with flunixin meglumine (1 mg/kg IV q12h). The weanling was small for its age
despite having received regular preventative health care and physical examination
revealed no other significant findings. A complete blood count revealed a normal white
blood cell count (7.7 x103/dL) with a neutropenia (14%) and lymphocytosis (84%). The
serum biochemistry abnormalities included hypoproteinemia (3.6g/dL) and
hypoalbuminemia (1.8g/dL)(Table A.1). EPE was tentatively diagnosed, and treatment
was initiated with oxytetracyclinei (10 mg/kg IV q24hr). At the time antimicrobial
treatment was initiated, the colt was eating and had normal vital sign values. Four hours
after examination, the colt developed peracute signs of shock and gastrointestinal crisis,
including tachycardia (108 bpm), tachypnea (40-50 bpm), dark purple mucous
membranes, and general signs of severe abdominal discomfort (rolling on the ground).
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Despite emergency intravenous fluid resuscitative care consisting of IV crystalloids (7
ml/kg bolus) and colloids (2 ml/kg bolus), the weanling quickly became recumbent and
died less than 45 minutes into the crisis and approximately 24 hours after initial
presentation.

Necropsy Findings:
Necropsy findings involving the small intestine were similar in all 4 cases.
Segments of the mucosa of jejunum, ileum, or both were thickened (cases #1- 4), variably
reddened (cases #1, 2, and 4), and corrugated (cases #2 and 4). Regions of ulceration and
greenish-brown necrotic mucosal plaques were occasionally evident (case #3). Peyer’s
patches were hemorrhagic (case #4), and the intestinal lumen contained a moderate
amount of dilute reddish-brown fluid (cases #1, 3, and 4). The cecal and colonic walls
were moderately edematous in cases #2 and 3. Additional lesions identified at necropsy
included: pneumonia and gastric ulcers (case #1); cestodiasis, fibrinous peritonitis, and
vegetative valvular endocarditis (case #2); multiple acute renal infarcts (case #3); and
mesenteric lymphadenopathy (case #4).
L. intracellularis was associated with the small intestinal lesions in all 4 cases. L.
intracellularis DNA was detected in ileal mucosal scrapings by PCR in all four cases. L.
intracellularis specific immunohistochemistry was performed on two cases (#2 and 4)
and directly identified the bacterium in the necrotic lesions of both cases.
Various bacteria were cultured from the intestines and systemic organs; culture
results and tetracycline antibiograms, given that tetracycline-class drugs are typically the
first antimicrobial administered to animals with suspected EPE in central Kentucky,11 are
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presented in Table A.2. The gram positive cocci noted in the abdominal fluid sample of
case #2 were not noted at necropsy. This could possibly be due to the administration of
antimicrobials or the cocci were anaerobic and not cultured at necropsy.
Histologically, small intestinal lesions were morphologically diagnosed as severe
subacute segmental necroulcerative enteritis (cases #1 and 4) or severe chronic segmental
proliferative and necroulcerative enteritis (cases #2 and 3). All 4 cases exhibited regions
of mucosal necrosis, erosion, and ulceration that were covered by mats of small amounts
of fibrin, cell debris, and acidophilic proteinaceous material, low number of neutrophils
and macrophages, and mixed populations of bacteria (Figures 3 and 4). The lamina
propria and submucosa, subjacent to the ulcers, were edematous and infiltrated with low
numbers of neutrophils, macrophages, and lymphocytes. Multifocal blood vessels
contained fibrin thrombi. Additionally in cases #2 and 3, multifocal regions of the
mucosa were proliferative and exhibited elongated villi, branched crypts, and crypt and
glandular epithelial hyperplasia. Few crypts contained cell debris and acidophilic
proteinaceous material. Tertiary findings included: necrotizing glomerulonephritis,
hepatitis, and embolic pneumonia (case #1); vegetative valvular endocarditis and
peritonitis (case #2); renal infarction (case #3); and renal glomerular thrombosis (case
#4).
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Table A.2. Bacteriology results obtained at necropsy. Includes the bacterial species, isolation location, and tetracycline-class
antimicrobial sensitivity.
Tetracycline/Doxycycline
Case #
Bacterium
Isolation Location
Sensitivity
Streptococcus zooepidemicus
Lung
Susceptible
1
E. coli
Liver
Moderately Susceptible
Actinobacillus equuli subsp equuli
Lung
Resistant
Actinobacillus equuli subsp equuli
Peritoneal cavity
Not Reported
2
E. coli
Heart
Resistant
No pathogenic organisms isolated
N/A
N/A
3
E. coli
Small intestine
Resistant
4
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Figure A.1: Ileum, age-matched control. Villi are distinct and of normal length.
H&E (40X total magnification). Bar = 1mm
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Figure A.2: Ileum, chronic EPE. Villi are segmentally blunted and fused. Crypts
are hyperplastic, elongated, and multifocally branched. H&E (40X total
magnification). Bar = 1mm

Figure A.3: Ileum, necrotizing EPE, case 2. Villi are shortened and the crypts are
mildly hyperplastic. Superficial villar tips are necrotic and covered by small
amounts cell debris. H&E (40X total magnification). Bar = 1mm

Figure A.4: Ileum, necrotizing EPE, case 2. Higher magnification of the necrotic
villar tips. H&E (400X total magnification). Bar = 100um

Discussion

Proliferative enteropathies induced by Lawsonia intracellularis infections have
been noted to occur in a variety of species worldwide. Most notable is L. intracellularis
infection in pigs where financial losses from porcine proliferative enteropathy are
significant.7 The majority of what is known with respect to L. intracellularis has been
discovered from work in pigs and largely extrapolated to the horse. Porcine proliferative
enteropathy exhibits several clinical entities, including the subclinical form in which
affected pigs exhibit no clinical signs but shed the bacterium, the chronic form where
affected pigs fail to grow as well as littermates, and the acute form (normally referred to
as porcine hemorrhagic enteritis or PHE), which is often characterized by hemorrhagic
diarrhea and acute death. While acute morbidity and mortality has long been recognized
as a common clinical presentation of Lawsonia intracellularis infection in swine,1 this
clinical presentation has never, to the authors’ knowledge, been described in multiple
field cases of EPE. Here we have presented four cases detailing an acute clinical entity
with necrotic enteritis, which we suggest be referred to as a necrotizing form of EPE (NEPE). This designation serves to provide not only a pathologic description, but also an
inference to the observed severity of clinical disease and rapid deterioration of the
affected animal.
With EPE, clinical signs of anorexia, dependent edema secondary to
hypoproteinemia and hypoalbuminemia, depression, lethargy, and weight loss are
typically observed during the fall and winter months (August-February);11,19,20 fever,
colic, and diarrhea are less frequently seen. Ultrasonographic detection of thickened

small intestinal walls in weanlings is highly suggestive of EPE, although the finding can
be inconsistent.11 Clinical cases of EPE generally develop slowly over several days, but
during an EPE challenge study one challenged weanling developed what we termed
"acute EPE" given the rapid deterioration and necrotizing enteritis that was noted in the
weanling.10 Since this was an experimental challenge study that likely failed to
adequately replicate the field conditions in which L. intracellularis infection is typically
contracted, we surveyed local practitioners for other, "acute EPE" cases. During the span
of thirteen months (October 2010-November 2011), the four cases detailed above were
identified in the central Kentucky region. A literature review found that the first
published description of EPE by Duhamel and Wheeldon13 recounted the acute
deterioration (5 days) and death of a foal, similar to the 24-96 hour time courses of our
cases, whereas a more recent report documented the occurrence of necrotizing enteritis
associated with L. intracellularis infection in one horse with a 10+ day history of EPE.130
Based on the short timeframe in which we selected cases, as well as the occasional report
of various facets of the N-EPE clinical entity, it is highly likely that cases of N-EPE have
occurred with regularity and simply not been recognized until now. Likewise, the
previous case of "acute EPE" we reported10 should, instead, be considered a case of NEPE based on the criteria listed above. Given that not all cases of N-EPE will expire as a
result of EPE or secondary bacterial infections, practitioners may elect to diagnose
surviving animals with "acute clinical EPE" and reserve N-EPE as a pathologic
diagnosis.
In pigs, it has been suggested that Lawsonia associated necrotic enteritis develops
from inflammation and necrosis induced by secondary bacterial invaders.131 The clinical

signs observed with these four weanlings were highly unusual for EPE. Damage induced
to the intestinal mucosal barrier by secondary pathogens likely predisposed these
weanlings to endotoxemia or bacteremia and resulted in secondary systemic sequelae.
This assertion appears to be supported by the presence of thickened mucosa associated
with the necrotizing and ulcerative enteritis, suggesting that alimentary damage preceded
bacterial translocation. The clinicopathologic, gross necropsy, and histologic findings in
cases #1 and #2 suggest that the observed clinical signs resulted directly from secondary
bacteremia. Interestingly, these two cases originated from the same farm but 12 months
apart. Finding regular, yearly cases of EPE on certain farms has been reported
previously,19,20 but the occurrence of two separate cases of N-EPE on the same farm in
different years is a novel finding. This could suggest that the particular strain of L.
intracellularis on this farm is potentially more virulent and that this farm should monitor
diligently for reoccurrence of N-EPE. Case #3 survived the longest after initial
presentation (~96 hours); however, treatment for EPE was not started until approximately
72 hours post-presentation. This weanling appeared to develop fulminant disseminated
intravascular coagulation after treatment was initiated, as demonstrated by the occurrence
of uncontrolled epistaxis, hematuria, melena/hematochezia, and multiple renal infarcts.
Possible causes for the development of DIC in this weanling include
septicemia/bacteremia, endotoxemia, or a decrease in circulating antithrombin-3 due to
hypoproteinemia. The last case, Case #4, survived for the shortest amount of time (<24
hours post-presentation) and was the only weanling to die spontaneously. Based on the
renal glomerular tuft thrombosis, this weanling likely died due to cardiovascular
compromise initiated by acute DIC.

Equine proliferative enteropathy has been a disease viewed as having a welldefined clinical presentation and a high treatment success rate when properly
diagnosed.11,19,30 The cases presented here provide an important repudiation to this
commonly held view in that, despite the correct preliminary diagnosis and appropriate
treatment, all four of these weanlings succumbed to complications arising from EPE.
This would suggest that treatment of N-EPE cases (those with signs of secondary
bacterial infection and/or endotoxemia) should be treated aggressively with broadspectrum antimicrobials to ensure coverage against both Gram-positive and Gramnegative bacteria, anti-thrombotics, and anti-endotoxic measures such as low-dose
flunixin meglumine27 and/or intravenous polymyxin-B.28 Care must be taken, however,
when administering NSAIDs and/or polymyxin-B due to their potential nephrotoxic
effects in patients with hypovolemia or in which there is a predisposition for azotemia:
additionally, NSAID use could exacerbate existing mucosal compromise. While no
anaerobes were isolated from the cases presented above, practitioners should be aware of
the possibility of secondary infections with anaerobic bacteria and consider
metronidazole treatment if they believe it to be warranted.
More work is needed to understand the risk factors for the development of NEPE, which could include environmental/husbandry differences, genetic
polymorphisms,127 the infectious dose, L. intracellularis strain, concurrent disease, or
animal’s immune status. Our previous work with an experimental challenge model
seems to suggest that the host immune system likely plays the largest role in this type of
clinical presentation as the infectious dose and strain used in that study was consistent
across six challenged weanlings, yet only one developed N-EPE;10 however, based on the

occurrence of two N-EPE cases on the same farm in consecutive years, a significant role
of bacterial strain cannot be ruled out. Regardless, practitioners must be cognizant of the
necrotizing form of EPE as weanlings may fail to demonstrate the classic, chronic clinical
signs associated with EPE (including weight loss and dependent edema) and/or require
emergency treatment to prevent secondary complications such as septicemia,
endotoxemia, and DIC, all of which could ultimately lead to acute death.
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